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Abstract

As a consequence of aging, the brain is subject to chronic
neuroinflammatory conditions. The resident immune cells of the brain,
microglia, act similarly to peripheral macrophages to protect the brain
from insults, infection, and physical trauma. However, without proper
regulation of their respective host defense mechanisms, these actions
can become neurotoxic. In the healthy brain neurons have several
signaling systems that directly interact with microglia in order to
maintain a calming influence upon their actions, one of particular
interest is the chemokine CX3CL1. This chemokine is found
predominantly on neurons, while its cognate receptor CX3CR1 is found
exclusively on microglia. There has been a recent surge in literature as
to the exact role CX3CL1 signaling plays various physiological and
neuropathological animal models, with still no well-defined role. In an
attempt to address the current discordance regarding the role of
CX3CL1 signaling we have used three different models. The first
examines how genetic ablation of CX3CR1 impacts hippocampal
dependent cognitive function. Secondly, we examined the impact of
chronic LPS-induced neuroinflammation affects CX3CL1 signaling and
ultimately cognitive function. Lastly, we used an acute mouse model of
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Parkinson’s disease induced by MPTP to examine the effects of specific
subtypes of CX3CL1. Although three unique approaches were used to
examine the anti-inflammatory properties of CX3CL1, parallels can be
drawn from the separate studies as similar results were obtained.
CX3CL1 signaling has significant anti-inflammatory actions within the
brain and alterations that prevent this signaling to occur can result in
impairments in cognitive function as well as exacerbation of
neurodegenerative conditions.
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Introduction
Neuroinflammation has been concomitantly linked with aging
and the progression of most neurodegenerative diseases including
Alzheimer’s (AD), Parkinson’s (PD), multiple sclerosis, amyotrophic
lateral sclerosis, stroke, and traumatic brain injury to name a few
(Popovich 2000; McGeer, Klegeris et al. 2005; Boillée, Vande Velde et
al. 2006; Wang, Tang et al. 2007; Hirsch and Hunot 2009; Weiner
2009). Much work in the neuroscience community has been dedicated
to studying the underlying mechanisms involved in the propagation of
inflammatory events and conditions in the central nervous system
(CNS). As a general summation, inflammation can be best described
as the body’s natural reaction to insults, pathogens, tissue damage,
and other deleterious stimuli. This response is typified by activation of
immune regulatory systems, whereby a variety of cellular signaling
events are orchestrated in an effort to provide host defense. While
these synchronized responses are designed for protection, they can
become dysfunctional in various disease conditions resulting in an
imbalanced response both in the periphery and CNS.
!
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Microglia
Microglia are the resident immune cells in the CNS and thus the
main inflammatory effectors in neurodegenerative diseases. Acting in
parallel to the innate immune cells found in the periphery, microglia
constitutively express a variety of cell-surface receptors, including toll
like receptors (TLR), complement receptors, major histocompatibility
complex (MHC) II, cytokine receptors, chemokine receptors, and
others (Aloisi 2001). These receptors work in concert to trigger or
amplfy an innate immune response within the CNS. Such a response
can be observed when microglia are exposed to lipopolysaccharide
(LPS), which is an endotoxin comprising the outer membrane of gramnegative bacteria. Microglial response to LPS exposure has been well
characterized by their upregulation in the production and secretion of
proinflammatory cytokines such as interleukin one beta (IL-1β), tumor
necrosis factor alpha (TNFα), and interleukin six (IL-6) (Lee, Liu et al.
1993). Although neurons and astrocytes have been shown to produce
inflammatory cytokines, their contribution has been shown to be
minimal by comparison (Lee, Liu et al. 1993). Therefore, microglia are
not only the sole innate immune effectors of the CNS, but must be
considered as the primary supplier of inflammatory signaling molecules
(Aloisi 2001). Microglia are dynamic in function in that they are
constantly surveying their surrounding microenvironment for danger
!
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signals such as neuronal damage. When neuronal damage occurs,
microglia will effectively move to the site of damage, guided by various
signaling gradients emanating from the damaged site/cell (Davalos,
Grutzendler et al. 2005; Nimmerjahn, Kirchhoff et al. 2005). This
dynamism comes through the extension and retraction of the cell’s
processes, allowing microglia to be in a constant state of adaptive
remodeling (Nimmerjahn, Kirchhoff et al. 2005).
Roles of microglia in aging and disease
While microglia in the brain are homogeneous in lineage, they
are heterogeneous in nature. There has been much attention and
effort to classify microglia based upon their neuroinflammatory
phenotype by adopting knowledge of T-cell responses from the
peripheral immune system(Mosser and Edwards 2008; Martinez,
Helming et al. 2009). This research has led to the loose establishment
of three microglia activation states (Mosser and Zhang 2008). The
most well studied phenotype known as “classical activation” or
Th1/M1. This activation state represents the initial phase of the CNS
innate immune response. M1 polarization of microglia is characterized
by the activation of these cells from LPS, interferon-γ!(IFN-γ), and
various cytokines, akin to peripheral macrophages. Microglia of this
phenotype are further characterized by antigen presentation and
production of toxic levels of oxidative and nitrosative intermediates, as
!
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well as increased pro-inflammatory cytokine production (Mantovani,
Sica et al. 2004). Due to the intrinsic nature for producing potentially
toxic levels of inflammatory mediators and perpetuating inflammation,
M1 phenotype is the perhaps the best studied. While M1 activation is
functionally the innate response to various insults in an effort to
maintain host (brain) defense, there is another end to the spectrum
regarding microglia activation to promote wound healing. These
microglia/macrophages are representative of the Th2/M2 phenotype or
“alternate activation” (Mosser and Edwards 2008). Characteristically,
these cells produce very little pro-inflammatory cytokines. Instead,
high levels of arginase activity are detected (Mosser and Edwards
2008; Mosser and Zhang 2008; Martinez, Helming et al. 2009). One
function of arginase is conversion of precursors to collagen, which
contributes to production of the extracellular matrix (Raes, De
Baetselier et al. 2002; Colton, Mott et al. 2006; Mosser and Zhang
2008). The proposed polarity between activation states is somewhat
ambiguous however, as there is a defined phenotype for M1, while the
M2 label encompasses activation states that include everything not
M1-like in nature (Mosser and Edwards 2008). This ambiguity yields
distinct subclasses of M2 activation, presenting a third type known as
“acquired deactivation” (Mosser and Zhang 2008). In this subclass of
M2, the primary response of microglia sharply contrasts with M1 to up!
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regulate the production of growth factors, which ultimately act to
resolve an inflammatory response. The inherent plasticity of microglia
activation then yields a wide array of response in the brain ranging
from inflammatory, to a build and repair mode, and finally to a calming
or anti-inflammatory state.
Innate immunity in cognitive function and disease
The current knowledge regarding the activation of microglia and
their respective roles in the brain implicates a dichotomous function
wherein they serve as both neuroprotective and neurodegenerative.
The responsibilities of microglia are quite vast when considered in the
context of multiple diseases that affect the brain. For instance, it must
be appreciated that such responses must be sufficiently distinct when
considering stroke or traumatic brain injury compared to AD. In the
case of the former neuronal death occurs very rapidly
(minutes/hours), while in AD neuronal dysfunction and death occurs
over years or decades!(Ransohoff and Perry 2009). Post stroke, a rapid
response is needed to clear necrotic cells and tissue, however
modulation of activated microglia is needed to avoid a chronic
degenerative state. In contrast, in AD a combination of events are
occurring over a long stretch of time as a result of misfolded protein
(Perry, Cunningham et al. 2007). In this case, microglia too need a
rapid response but rather possess a malleable role. It is therefore
!
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difficult to have a broad-spectrum approach to the control of microglia
toxicity when such a varied response is needed.
The ability to remember is predicated on the brain’s capacity to
form strong and efficient synaptic connections. These connections are
in turn maintained by de novo expression from a variety of genes,
which mediate synaptic plasticity (Rosi 2011). Importantly,
dysfunction of hippocampal synaptic plasticity is associated with aging
and many inflammation propagated neurodegenerative diseases such
as AD, autism, and multiple sclerosis (McGeer and McGeer 1998;
Akiyama, Barger et al. 2000; Mhatre, Floyd et al. 2004). While
dysfunctional neurons cause the functional disorder of these diseases,
alterations of their local niche may play an important factor in disease
progression. It is therefore relevant to consider how microglia
activation plays an integral role in neuronal function and synaptic
plasticity.
Although neuroinflammation is needed for host defense to
protect against various insults (exogenous or endogenous),
unregulated responses can be toxic. It is difficult to pinpoint a
causative mechanism related to neuroinflammatory initiated cognitive
impairments as a whole. However, in the context of the hippocampus,
the role in which neuroinflammation may alter cognitive function could
be its adverse impact on neurogenesis (Bachstetter, Pabon et al.
!
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2008; Bachstetter, Morganti et al. 2009). Neurogenesis in the dentate
gyrus (DG) of the hippocampal formation has been consistently linked
hippocampal-dependent memory function (Imayoshi, Sakamoto et al.
2008). Interestingly, there’s a direct correlation between the increase
of infiltrating granule cells in the hippocampus with hippocampal
dependent memory function (Shors, Miesegaes et al. 2001). The
relevance of infiltrating granule cells into the hippocampus can be
appreciated due to their ability to develop into mature neurons,
exhibiting the synaptic responsiveness as their surrounding
contemporaries (Song, Stevens et al. 2002). It is here where the
inflammatory response of microglia has been implicated in creating
unfavorable neurogenic microenvironments. Equally, aberrant
activation of microglia has been shown to be toxic to not only
new/infiltrating granule cells, but mature neurons as well (Monje and
Palmer 2003). Furthermore, blocking neuroinflammation through
various targets can restore or even increase neurogenesis (Monje,
Toda et al. 2003; Gemma, Bachstetter et al. 2007; Das and Basu
2008).
Neuroinflammation is a common denominator among many
neurodegenerative diseases and, more often than not, is a culprit in
the propagation of the disease. PD is a characteristic
neurodegenerative disease where aberrant microglia activation and
!
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subsequent neuronal toxicity are hallmarks (Block and Hong 2005;
Ransohoff and Perry 2009)The substantia nigra, the affected area in
PD, has been shown to contain roughly 4.5 times the population of
microglia compared to other areas of the brain (Kim, Mohney et al.
2000), potentially predisposing these neurons to greater microglial
insults (Block and Hong 2005). The exact mechanism involving the
deleterious effects of microglia on dopaminergic neurons is still
evolving. Complicating the situation even more is that dopaminergic
neurons have a greater susceptibility to oxidative stress from microglia
due to reduced levels of glutathione (Loeffler, DeMaggio et al. 1994).
Furthermore, a role for microglia-mediated neurotoxicity in PD is that
mice, which are genetically altered to inhibit cytokine production or are
deficient in receptors for cytokines, provide neuroprotection (Klevenyi,
Andreassen et al. ; Sriram, Matheson et al.). As such, it is relevant to
address methods that regulate of microglia-initiated inflammation and
subsequent neurotoxicity,
Fractalkine and CX3CR1
Recent evidence indicates that neurons are not only passive
targets of microglia but rather can control microglia activity. An
important area of investigation is to examine neuronal-glia
interactions, as this is one way that neurons can signal inflammatory
cells that a response is needed. Under resting conditions there are
!
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several neuronal mediated signals that have an anti-inflammatory
action at the level of microglia. One of high interest in the literature is
the chemokine CX3CL1 (FKN). FKN is expressed constitutively by
healthy neurons and it has been identified as a novel neuroimmune
regulatory protein, whose function is to send alert signals to microglia,
and inhibit microglia activity under inflammatory conditions (Harrison,
Jiang et al. 1998; Ransohoff, Liu et al. 2007). Compared to most
chemokines, FKN is unique in size and structure. FKN in its full-length
form is approximately 100 kDa in weight, compared to 8-14kDa of
most common chemokines, and comprises an intracellular
transmembrane domain as well as a glycosolated mucin-like stalk
(Bazan, Bacon et al. 1997; Imai, Hieshima et al. 1997; Rossi,
Hardiman et al. 1998)Furthermore, FKN is unique among the large
super-family of chemokines in that it is the only member to have a
CX3C-arrangement of its conserved cysteine residues (MaciejewskiLenoir, Chen et al. 1999). Additionally, FKN ligates and activates only
a single receptor, CX3CR1. Ligation and signaling from FKN can occur
via two mechanisms; the chemokine domain can be shed, to form a
soluble form, from the membrane via a disintegrin and
metalloproteinase 10 (ADAM10) and TNFα converting enzyme
(TACE/ADAM17), or chemokine domain may remain tethered to the
membrane in a signaling capable full-length form (Garton, Gough et al.
!
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2001; Hundhausen, Misztela et al. 2003; Hundhausen, Schulte et al.
2007). Expression of FKN is ubiquitous however; only certain cell types
in the CNS and periphery have been shown to produce it. Within the
CNS, FKN is constitutively produced by neurons, with a few instances
where it may be induced or upregulated in astrocytes depending upon
insult or disease (Harrison, Jiang et al. 1998; Yoshida, Imaizumi et al.
2001; Guillemin, Croitoru-Lamoury et al. 2003). Interestingly, FKN and
stromal cell-derived factor-1 (SDF-1/CXCL12) are two of the only
known constitutively expressed chemokines found in neurons (Crump,
Gong et al. 1997; Mizoue, Bazan et al. 1999). Furthermore, recent
data have implicated a unique relationship between FKN and SDF-1,
wherein SDF-1 has been implicated in stimulating the actions of
ADAM10/17 upon FKN to produce its secreted form (Cook, Hippensteel
et al. 2010). Outside of the CNS, FKN expression is found on several
cells types; endothelial, epithelial, and smooth muscle cells (Bazan,
Bacon et al. 1997; Ludwig, Berkhout et al. 2002; Teupser, Pavlides et
al. 2004). In terms of the CNS, several studies have suggested a
continuous dialog between neurons and microglia under basal
conditions via FKN and its cognate receptor CX3CR1 (Ransohoff, Liu et
al. 2007). This interaction between FKN and CX3CR1 contributes to
maintain microglia in a resting phase. Both in vivo and in vitro FKNCX3CR1 dialog has been shown to hamper production of multiple pro!
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inflammatory mediators such as iNOS, IL-1β, TNFα, and IL-6, as well
as confer neuroprotection against various insults and disease models
(Harrison, Jiang et al. 1998; Boehme, Lio et al. 2000; Meucci, Fatatis
et al. 2000; Zujovic, Benavides et al. 2000; Zujovic, Schussler et al.
2001; Zujovic and Taupin 2003; Cardona, Pioro et al. 2006;
Bachstetter, Morganti et al. 2009; Lyons, Lynch et al. 2009; Lyons,
McQuillan et al. 2009; Pabon, Bachstetter et al. 2011). Therefore,
disruption of this dialog could trigger changes in the functional
phenotype of microglia.
FKN cognate receptor is CX3CR1, which is expressed solely by
microglia in the CNS. In the periphery, CX3CR1 can be found on a
variety on circulating immune cells including monocytes, dendritic
cells, certain T-cells, and natural killer cells (Harrison, Jiang et al.
1998). It is therefore difficult to generalize the exact nature of FKNCX3CR1 given the variety of cells capable of ligation with FKN.
Furthermore, this signaling pair’s interactions vary according to their
resident tissues and as of recently, various disease models. A dual role
for FKN and CX3CR1 are observed in the literature raising the question
as to the risk/benefit of FKN-CX3CR1 signaling as a therapeutic tool.
As mentioned above, within the brain the majority of literature seems
to indicate a calming effect produced by FKN ligation to CX3CR1.
Conversely, in different models of AD genetically blocking FKN-CX3CR1
!

!

12!

signaling can be either neuroprotective!(Lee, Varvel et al. 2010; Cho,
Sun et al. 2011) or neurodegenerative (Fuhrmann, Bittner et al.
2010). Additionally, in humans there are 2 polymorphisms for the
CX3CR1, one of which caused reduced adhesion, signaling and
chemotaxis. The variant with reduced adhesion is protective for
atherosclerosis (McDermott, Fong et al. 2003) yet increases the risk of
macular degeneration (Tuo, Smith et al. 2004). Comparatively,
CX3CR1 null mice show markedly increased cytokine storm in response
to lipopolysacharide (LPS) resulting in a subsequent increase in cell
death in the hippocampus. CX3CR1 null mice also show increased
susceptibility to neurotoxins such as MPTP (Cardona, Pioro et al.
2006), presumably by an increased classical activation state of
microglia.
An aspect of FKN-CX3CR1 signaling that may play an important
role in the differential effects of FKN is its ability to ligate CX3CR1 as
both a soluble and membrane-bound chemokine. FKN is cleaved at a
dibasic arginine sequence adjacent to the cell membrane to produce a
soluble form of its signaling domain (Ré and Przedborski 2006). The
exact roles of these subtypes of FKN are not completely established in
the periphery or in the CNS. It has been shown that the membrane
bound form plays a role in endothelial cell death (Yoneda, Imai et al.
2003) whereas exogenous soluble FKN has been shown to be both
!
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neuroprotective (Pabon, Bachstetter et al. 2011) and
neurodegenerative (Shan, Hong-Min et al. 2011). Recently, Lyons et
al. (2009) (Lyons, Lynch et al. 2009) were able to show a significant
reduction in microglia activation in vitro using exogenous soluble FKN.
Furthermore, they concluded that the membrane-bound form of FKN
possesses the same abilities, however due to their experimental
parameters it is unclear whether signaling was achieved solely from
the membrane-bound subtype. Importantly, the authors neglected to
prevent the potential cleavage by ADAM10/17, which would result in
the production of the soluble subtype. Therefore, the physiological
significance of both subtypes of FKN still remains ambiguous.
Conclusion
The overall hypothesis that underlies the focus of this
dissertation is that disruption in neuron to microglia interaction leads
to inflammation. Furthermore, this disconnect establishes an
environment that is at least permissive and perhaps a critical
contributor towards the inflammation-mediated decline in synaptic
plasticity, and for the progression/exacerbation of neurodegenerative
diseases, such as in PD. The following chapters of this dissertation
address three distinct models in which neuron to microglia
communication has been altered and how the CX3CL1 signaling plays a
vital role to maintain microglia in a resting state.
!
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CX3CR1 deficiency leads to impairment of hippocampal
cognitive function and synaptic plasticity

Note to Reader
Portions of these results have been previously published (Rogers
et al. 2011) and are utilized with permission from the publisher.
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Abstract
The protective/neurotoxic role of fractalkine (CX3CL1) and its
receptor CX3C chemokine receptor 1 (CX3CR1) signaling in
neurodegenerative disease is an intricate and highly debated research
topic and it is becoming even more complicated as new studies reveal
discordant results.

It appears that the CX3CL1/CX3CR1 axis plays a

direct role in neurodegeneration and/or neuroprotection depending
upon the CNS insult.

However, all the above studies focused on the

role of CX3CL1/CX3CR1 signaling in pathological conditions, ignoring
the relevance of CX3CL1/CX3CR1 signaling under physiological
conditions.

No approach to date has been taken to decipher the

significance of defects in CX3CL1/CX3CR1 signaling in physiological
condition.

In the present study we used CX3CR1-/-, CX3CR1+/- and

wild-type mice to investigate the physiological role of CX3CR1 receptor
in cognition and synaptic plasticity.

Our results demonstrated for the

first time that mice lacking CX3CR1 receptor show contextual fear
!
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conditioning and Morris water maze deficits.
affects motor learning.

CX3CR1 deficiency also

Importantly, mice lacking the receptor have a

significant impairment in long term potentiation (LTP).

Infusion with

IL-1b receptor antagonist significantly reversed the deficit in cognitive
function and impairment in LTP. Our results reveal that under
physiological conditions, disruption in CX3CL1 signaling will lead to
impairment in cognitive function and synaptic plasticity via increased
action of IL-1b.

INTRODUCTION
Microglia are the resident immune cells in the central nervous
system (CNS) that act as macrophages (Harrison, Jiang et al. 1998;
Aloisi 2001).

Microglia can rapidly respond to the detection of

homeostatic disturbances by inducing an immune response, which
consists of a transient, up-regulation of inflammatory molecules and
neurotrophic factors (Miwa, Furukawa et al. 1997; Batchelor,
Liberatore et al. 1999; O'Donnell, Vereker et al. 2000; Nakajima and
Kohsaka 2004). Through this immune response, microglia protect
proper brain function and remove cells damaged from an acute injury.
When chronic inflammation occurs, prolonged activation of microglia
trigger the release of several neurotoxic products and proinflammatory

!
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cytokines including IL-1b, IL-6, and Tumor necrosis factor (TNFa)
(Colton and Gilbert 1987).
Microglia are restrained by numerous micro-environmental
influences, many of which are produced by neurons (Cardona, Pioro et
al. 2006; Hanisch and Kettenmann 2007; Lyons, Downer et al. 2007).
Fractalkine (CX3CL1) is a chemokine that is constitutively expressed
by healthy neurons and identified as a novel neuroimmune regulatory
protein. CX3CL1 ligates to microglia, which inhibits microglial activity
under inflammatory conditions (Harrison, Jiang et al. 1998; Ransohoff,
Liu et al. 2007). In contrast to other chemokines, CX3CL1 binds to
only one receptor, CX3CR1 (Harrison, Jiang et al. 1998).

In the brain

CX3CR1 is exclusively expressed by microglia (Harrison, Jiang et al.
1998). CX3CL1 can bind to CX3CR1 either as a membrane bound
protein or a soluble ligand following constitutive cleavage by ADAM10
and ADAM17 metalloproteases (Bazan, Bacon et al. 1997).
Interactions between CX3CL1 and CX3CR1 contribute to microglial
ability to maintain a resting phenotype.

However, when neurons are

injured, CX3CL1 levels decrease, which results in microglia recruitment
and activation.
Through interactions with microglia, CX3CL1 serves as an
endogenous neuronal modulator and controls the over-production of
iNOS, IL-1b, TNFα and IL-6.
!
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has been linked to human neurodegeneration, highlighted by the
identification of the V249I and T280M polymorphisms in CX3CR1.
These polymorphisms are associated with the neuroinflammatory
disorder, human age-related macular degeneration (Tuo, Smith et al.
2004; Chan, Tuo et al. 2005).

Furthermore, mice that are deficient in

CX3CR1 have increased microglial cell expression of IL-1β in response
to lipopolysacharide (LPS) stimulation.

This increased IL-1β

expression is associated with increased neuronal cell death in the
hippocampus (Cardona, Pioro et al. 2006; Ransohoff, Liu et al. 2007)
and CX3CR1-deficent mice have increased susceptibility to neurotoxins
such as MPTP (Cardona, Pioro et al. 2006). However, all of the studies
mentioned have focused on the role of CX3CL1/CX3CR1 signaling in
pathological conditions, ignoring the relevance of CX3CL1/CX3CR1
signaling under physiological conditions.

Our lab has previously

established the impact of functional disruption of CX3CR1 in a nonpathological condition.

We have demonstrated that CX3CR1-/- mice

have decreased hippocampal neurogenesis(Bachstetter, Morganti et al.
2009).

Furthermore, antagonism of CX3CR1 in young rats leads to

increased hippocampal protein levels of IL-1b and decreased
neurogenesis.

We hypothesize that disruption of CX3CL1/CX3CR1

signaling will result in alterations of the physiological activities of the
brain.
!

Here, we demonstrate under physiological conditions,
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disruption of CX3CL1/CX3CR1 signaling leads to impairments in motor
learning, cognitive function and synaptic plasticity through increased
inflammation in the CNS.
MATERIALS AND METHODS
Animals.

All experiments were conducted in accordance with

the National Institute of Health Guide and Use of Laboratory Animals,
and were approved by the Institutional Animal Care and Use
Committee of the University of South Florida, College of Medicine or
the University of Florida, as appropriate.

CX3CR1-/- mice were

backcrossed to the C57BL/6J background for greater than 10
generations and were obtained from Jackson Laboratories (Bar Harbor,
Maine). Colonies of the CX3CR1+/- and CX3CR1-/- mice were
maintained at the University of South Florida and genotyping
performed as previously described (Bachstetter, Morganti et al. 2009).
Three month-old male CX3CR1+/- and CX3CR1-/- littermates and
C57BL/6J (wild-type) were used in the experiments.

Mice were pair-

housed in environmentally controlled conditions (12:12 h light:dark
cycle at 21 ± 1°C) and provided food and water ad libitum.

Animals

that developed skin lesions were excluded from the Morris water maze
test to avoid the development of infection.

!
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BrdU administration.

Three month-old male (n =

5/genotype) CX3CR1+/-, CX3CR1-/- littermates and C57BL/6 (wild-type;
WT) received two intraperitoneal (i.p.) injections within 12 hours
interval of bromodeoxyuridine (BrdU) (5-bromo-2-deoxyuridine;
Sigma, St. Louis, MO) at dose of 50 mg/kg.

Animals were

euthanatized 24 hours following the last injection.

Surgical procedure.

Three month-old male CX3CR1-/- and

C57BL/6 (wild-type; WT) mice were implanted with a brain infusion
cannula connected with an osmotic mini-pump.

Before implantation,

the pumps were incubated in sterile saline for at least 48 h at 37 °C to
prime the pumps.

For implantation, mice were anaesthetized with

isofluorane and placed in a stereotaxic frame.

A guide cannula was

implanted in the left ventricle AP, 1.0; ML, -0.5; DV, 2.5 mm) and
connected to the osmotic minipump (Alzet Model, 1004: pumping rate,
0.11 ml ⁄ h; total volume, 100 ml), which was inserted
subcutaneously.

Pumps were weighed before implantation and at the

end of the experiment to ensure complete delivery of their content.

r-

metHu IL-1ra, 100 mg/ml/day (kind gift from Amgen,Thousand Oaks
CA), was infused through the cannula which was connected to the
filled mini-pump.

The infusion started on the day of the surgery and

continued for 4 weeks.
!

Control animals received the same volume of
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heat-inactivated IL-1ra (heat-inactivated for 45 minutes in a water
bath at 90oC) or artificial cerebrospinal fluid (ACSF).

Behavioral

analysis started 15 days following the beginning of the infusion.

Mice

that during the course of behavioral testing showed signs of distress or
infections during to surgical procedure were not included in the
following behavioral studies.

Tissue collection and processing.

For immunohistochemistry

studies, animals were anaesthetized with pentobarbital (50 mg/kg,
i.p.).

The mice were transcardially perfused with phosphate-buffered

saline (PBS), followed by 4% paraformaldehyde in PBS.

The brains

were postfixed in 4% paraformaldehyde for 12 h, after which they
were transferred into 30% sucrose in PBS for at least 16 h at 4°C.
Exhaustive sagittal sections of the left hemisphere were made at 40µm
using a Microm cryostat (Richard-Allan Scientific, Kalamazoo Michigan)
and stored in cryoprotectant at 4°C.

Animals used for biochemical

studies were euthanatized by rapid decapitation.

Brain tissues were

separately dissected and rapidly frozen in liquid nitrogen before
storage at -80ºC.

Both hippocampi were homogenized using an

electric tissue homogenizer in 1:10 weight to volume ratio of ice-cold
RIPA buffer (Millipore; Billerica MA) containing protease inhibitors and
EDTA (Pierce; Rockford IL).
!

Following homogenization, sample
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lysates were centrifuged at 10,000 x g at 4ºC for 15 minutes, the
cleared supernatant was collected.
ELISA.

Total protein was measured using BCA assay (Pierce).

IL-1β and TNFα concentrations were measured using a commercially
available enzyme-linked immunosorbent assay (ELISA) kits
(eBioscience; San Diego CA) following manufacturer’s protocol.
Western blot analysis.

50 µg of total protein per lane was

loaded onto a 10% SDS-polyacrylamide gel (BioRad; Hercules CA) for
electrophoresis.

Proteins were transferred onto a nitrocellulose

membrane for immunodetection.

The membrane was blocked for 1-

hour in 5% non-fat dry milk (NFDM) in PBS-tween (PBS-T, 0.1%).
Antibodies for rabbit phospho-p38 (Cell Signaling; Boston MA, 1:1000)
and mouse beta-actin (Sigma; 1:3000) were incubated overnight at
4oC in 1% NFDM in PBS-T.

Following washes, anti-rabbit and anti-

mouse secondary antibodies (LiCor; Lincoln NE) were incubated for 1hour at room temperature in 1% NFDM in PBS-T.

Membranes were

scanned using LiCor Odyssey Imager and raw intensity for each band
was measured using LiCor Odyssey image analysis software.
Immunohistochemistry. Except where specifically indicated,
standard staining procedures were conducted on free-floating sections
using every sixth section for the entire hippocampus beginning with a
!
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random start and including sections before and after the hippocampus
to ensure that the entire structure was sampled.

Sections were

blocked in 10% normal serum from the species that secondary
antibody was raised in, with the addition of 0.1% Triton X-100.
Sections were incubated, with primary antibody (Abcam anti Iba1
1:500) diluted in 3% normal serum with 0.1% Triton X-100, overnight
at 4°C.

For immunohistochemistry biotinylated secondary antibodies

(horse anti-goat 1:2000) were diluted in 3% normal serum with 0.1%
Triton X-100 and were incubated for 2 hours at room temperature.
Enzyme detection was done using avidin-biotin substrate (ABC kit,
Vector Laboratories, Burlingame, CA) followed by color development in
diaminobenzidine solution (Sigma, St. Louis, MO).

For immuno-

detection of BrdU labeling, protocol was followed as previously
described (Bachstetter et al., 2009;Gemma et al., 2007).

Briefly,

sections were pretreated with 50% formamide/2× SSC (0.3 M NaCl,
0.03 M sodium citrate) at 65°C for 2 hours, rinsed in 2 × SSC.

BrdU

was detected using a mouse anti-BrdU (1:100; Roche; Indianapolis IN,
clone B44).

Doublecortin (DCX) is a marker of migrating neurons that

is expressed for approximately three weeks after the cell is born and
has been shown to be a reliable indicator of neurogenesis (Rao and
Shetty 2004; Couillard-Despres, Winner et al. 2005).

For DCX

immuno-detection, incubation in primary antibody was done for 36
!
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hours at 4°C using a polyclonal goat antibody C-terminus of human
DCX (1:200; Santa Cruz biotechnology, Santa Cruz, CA, USA).
Quantification and imaging. To determine cell numbers, the
optical fractionator method of unbiased stereological cell counting
techniques (West, Slomianka et al. 1991) was used with a Nikon
Eclipse 600 microscope and quantified using Stereo Investigator
software (MicroBrightField, Colchester, VT).

The virtual grid (175 x

175) and counting frame (100 x 100) were optimized to count at least
200 cells per animal with error coefficients less than 0.07.

Outlines of

the anatomical structures were done using a 10x/0.45 objective and
cell quantification was conducted using a 60x/1.40 objective.
Iba1 quantification. Slides with Iba1 stained sections were
scanned using a Zeiss Mirax slide scanner.

Following scanning, digital

images were analyzed for Iba1 positive staining using Zeiss
Neuroquant IAE analysis software.

Briefly, an investigator blind to the

study randomly placed a measurement grid within the DG of each HPC
section.

Each measurement grid had the same dimensions and

therefore same measurement area.

Iba1 positive cells were defined

in the analysis software based upon threshold to include both the cell
body and processes, while eliminating background values.

Data were

obtained solely from the randomly placed measurement grid on an
average of five sites per animal within the DG.
!

Raw data were
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normalized to account for variations in the number of sampling sites.
Results are given as the average ratio of Iba1 positive area relative to
total measurement area.
Behavioral analysis.
Rotarod. Aged-matched 3-month-old wild-type, CX3CR1-/-, and
CX3CR1+/- mice were first tested for overall balance, motor
coordination and motor learning.

This test was performed on an

accelerating rotarod apparatus (Ugo Basile, Italy) with a 3 cm
diameter rod starting at an initial rotation of 4 RPM accelerating to 40
RPM over 5 minutes.

Mice were tested for the time spent on the rod

during each of four trials with a 30 min inter-trial interval.

Each trial

was completed when the mouse fell off the rod (distance of 12 cm)
onto a spring-cushioned lever.
Open Field. The open field was used as a standard test of
general activity.

Animals were monitored for 15 minutes in a 40 cm

square open field with a video tracking software (ANY-Maze, Stoelting,
Illinois), under moderate lighting.

General activity levels were

evaluated by determining the total amount of distance traveled.
Anxiety levels were assessed by the pattern of exploration of in the
open-field (center versus periphery).

!
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Elevated Plus Maze. Anxiety was also assessed through the

elevated plus maze (EPM).

The EPM consisted of two well-lit open

arms (35 cm) facing each other and two enclosed arms (30.5 cm) also
facing each other.

Each arm is attached to a common center platform

(4.5 cm square) and elevated 40 cm off the floor.

The mouse was

placed in the center platform and allowed to explore for 5 min.

Video

tracking software measured movement in each section (ANY-Maze,
Stoelting, Illinois).
Fear Conditioning. Fear conditioning was used to assess
memory formation that is especially suited to test for proper
hippocampus function. Animals were placed in the fear conditioning
apparatus (Panlab, Spain) for 2 minutes, then a 30 second acoustic
conditioned stimulus (CS; 80 dB tone) was delivered and a 0.5 mA
shock (unconditioned stimulus-US) was applied to the floor grid during
the last 2 seconds of the CS. Training consisted of two CS-US pairings
with a 1.5 minute interval between each. The mice were placed in the
chamber and monitored for freezing to the context 24 hours after
training (no shocks or conditioned stimulus given). Immediately after
the contextual test, mice were placed into a novel context and
exposed to the CS for 3 minutes (cued fear conditioning). Learning
was assessed by measuring freezing behavior (i.e. motionless position)
for 2 consecutive seconds. Shock threshold was assessed by placing
!
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an animal in the same conditioning chamber as used for associative
fear conditioning. Foot shock intensity started at 0.075 mA and was
increased by 0.05 mA every 30 s. The shock intensity to induce
flinching, jumping, and vocalization were determined and the shock
intensity was recorded. The experiment was terminated at the shock
intensity sufficient to induce vocalization.

Morris Water Maze. The Morris hidden platform water maze
(MWM) consisted of a circular pool (1.38 m diameter) filled with nontoxic opaque water at room temperature with an escape platform (10
cm diameter) hidden beneath the water (3 cm). Each mouse was
placed in the pool in a pseudorandom order and given 60 seconds to
locate the escape platform. When the mouse found the platform or if
the mouse failed to find the platform within 60 seconds, it was placed
on the platform where it remained for 30 seconds. Each mouse was
given four trials per day with an inter-trial interval of 1 hour. The time
to find the platform (escape latency), the total distance traveled, and
the swim speed of the animals were recorded by video tracking
software (ANY-Maze, Stoelting, Illinois). The mice were then toweldried and placed in a cage with a heating pad underneath until dry and
!
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returned to their home cage. On day 7, all mice were subjected to one
probe trial in which the platform was removed and each animal had 60
seconds to search the pool for the platform. Since wild-type mice did
not show improvement in learning ability to find the platform on day 7,
a second probe trial was performed on day 11, following 3 additional
continuous days of training.
Extracellular Recordings. Mice were euthanatized by rapid
decapitation and hippocampi were dissected out for
electrophysiological experimental paradigms as previously described
(Weeber, Beffert et al. 2002; Beffert, Weeber et al. 2005; Peters, Hill
et al. 2006). Field excitatory post-synaptic potentials (fEPSPs) were
obtained from area CA1 stratum radiatum with the use of a glass
microelectrode filled with ACSF (2–4 mΩ). fEPSPs were evoked
through stimulation of the Schaffer collaterals using a 0.1 ms biphasic
pulse delivered every 20 s. After a consistent response to a voltage
stimulus was established, threshold voltage for evoking fEPSPs was
determined and the voltage was increased incrementally every 0.5 mV
until the maximum amplitude of the fEPSP was reached (I/O curve).
All other stimulation paradigms were induced at the same voltage,
defined as 50% of the stimulus voltage used to produce the maximum
fEPSP amplitude, for each individual slice. Paired-pulse facilitation
(PPF) was induced with two paired-pulses given with an initial delay of
!
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20 ms and the time to the second pulse incrementally increased 20 ms
until a final delay of 300 ms was reached.
LTP recordings. Slices that received IL-1ra (100 µg/ml kind gift
from Amgen, Thousand Oaks CA) were bathed in ACSF containing IL1ra for at least 15 min prior to the start of recordings. A fEPSP LTP
baseline response was recorded every 20 sec for 20 min. The tetanus
used to evoke LTP was high-frequency stimulation (HFS), which
consisted of 2 trains of 1 sec, 100 Hz pulses, with an inter-train
interval of 20 s. Following HFS, fEPSPs were recorded for 60 min. The
slopes of fEPSPs were averaged into 1 min bins and graphed.
Potentiation was measured as the increase of the mean fEPSP
descending slope following TBS normalized to the mean fEPSP
descending slope of baseline recordings.
PTP recordings. All hippocampal slices were bathed in ACSF
containing 50 uM APV for at least 15 min prior to recordings. Slices
that received IL-1a were bathed in ACSF containing IL-1ra for at least
15 min prior to the start of recordings. A fEPSP PTP baseline response
were recorded every 3 sec for 1 min. The tetanus used to induce PTP
was high-frequency stimulation (HFS), which consisted of a 1 sec, 100
Hz pulses. Following HFS, fEPSPs were recorded every 3 sec for 5
min. The slopes of fEPSPs were averaged into 12 sec bins and
graphed.
!

Potentiation was measured as the increase of the mean
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fEPSP descending slope following PTP normalized to the mean fEPSP
descending slope of baseline recordings.
DAPI Staining. Mice were sacrificed and hippocampi were
dissected out for DAPI staining in the exact same manner as
electrophysiological experimental paradigms. Hippocampal slices were
placed in a submerged holding chamber containing oxygenated ACSF
for no less than two hours before being transferred to 4% PFA for
fixation for approximately 16 hours. Following fixation, 40 µm sections
were made through entire dissected region and mounted on superfrost
slides. Visualization of cell nuclei was achieved using DAPI VectaShield
hardest mounting media (Vector Labs, Burlingame, CA). Fluorescent
images were taken using Olympus FluoView FV1000 confocal
microscope. Hippocampal DAPI positive cells were quantified from 16bit grayscale images using ImageJ software for each of the three
genotypes (n=5 per group).
Statistical Analysis. Statistical analysis comparing the 3
genotypes was done using a one-way analysis of variance (ANOVA) or
two-way ANOVA with the Tukey-Kramer or Bonferroni post-hoc test,.
Repeated Measure ANOVA was used to analyze Rotarod data, followed
Bonferroni post-hoc.
Prism software.

!

Statistical analysis was done in the GraphPad
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RESULTS
Decreased hippocampal neurogenesis in CX3CR1-deficient
mice in a gene-dose dependent manner. Previously, we
demonstrated that CX3CR1-/- young mice have a significant decrease
in hippocampal neurogenesis when compared to heterozygous
littermates. To determine whether both alleles are required for normal
receptor function, we counted the number of doublecortin (DCX)
positive cells in the subgranular zone (SGZ) of the dentate gyrus in
CX3CR1-/-, CX3CR1+/-, and wild-type mice. Using the optical
fractionator method of design-based stereology, we observed a
significant decrease in the number of DCX+ cells in the SGZ of the
dentate gyrus in CX3CR1-/- mice compared to CX3CR1+/- and wild-type
mice (Figure 1a; one-way ANOVA, p< 0.0001). Interestingly, loss of
one allele is sufficient to impair receptor function (Tukey’s post-hoc;
wt vs +/- , p< 0.001; wt vs -/-, p< 0.001; +/- vs -/-, p< 0.05). To
determine if this decrease is due to reduced cell proliferation, mice
were injected twice (8 hours interval) with BrdU (50mg/kg).

Mice

were euthanized the following day. Quantification of the number of
BrdU+ cells revealed a significant decrease in the number of BrdU+
cells in the CX3CR1-/- mice compared to the CX3CR1+/- and wild-type
mice, indicating reduced cell proliferation (Figure 1b; Tukey’s posthoc; wt vs +/-, p< 0.05; wt vs -/-, p< 0.001; +/- vs -/-, p< 0.05).
!
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Motor learning but not motor coordination is impaired in

CX3CR1 deficient mice. Coordination and motor skill acquisition
were tested using an accelerating rotorod. The amount of time an
animal stays on the rotorod is an indicator of its general level of
balance and coordination. In general, mice improve their performance
over time with training, which is an indicator of motor learning.

In

the first study, aged-matched littermate wild-type (n = 10), CX3CR1-/(n = 12) and CX3CR1+/- (n = 12) mice were tested for the time spent
on the rod during each of four trials per day, for two consecutive days.
No differences were observed between genotypes during the first day
of training (Fig 2a). On the second day of training (trials 5-8), wildtype mice remained on the rod for longer periods of time.

However,

neither the CX3CR1-/- or the CX3CR1+/- mice significantly improvement
motor coordination on the second day of training (Figure 2a; repeated
measures ANOVA, p<0.0001.). Wild-type mice performed significantly
better on trial 8 compared to trial 1 than did CX3CR1-/- and CX3CR1+/mice (Figure 2b), suggesting motor learning deficits in CX3CR1-/- and
CX3CR1+/- mice. There were no significant differences on the first trial
of testing between all experimental groups, which suggests that there
is no difference in baseline motor skills.

Taken together, these data

suggest that CX3CR1-/- and CX3CR1+/- mice have deficits in motor

!
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learning, indicating that cerebellar or striatal-dependent learning may
be compromised in these mice.
Absence of CX3CR1 receptor does not affect spontaneous
locomotor activity or cause excessive anxiety. To examine
spontaneous locomotor activity in response to a novel environment,
CX3CR1-/-, CX3CR1+/- and wild-type mice were tested in the open field
behavioral task. The open field task monitors activity in a brightly lit,
novel environment and is a necessary control for interpretation of
associative fear conditioning. Spontaneous locomotor activity was
assessed as the total amount of distance traveled in the chamber.
Also, anxiety levels can be measured in the open field task through
assessment of the distances traveled in the center versus perimeter of
the chamber. This task exploits the natural tendency of mice to avoid
open areas. There were no significant differences in total distance
traveled (Figure 2c). In addition, no differences were observed
between distance traveled in the center zone compared to the
perimeter zone and the time spent in each zone (data not shown).
Anxiety levels were also measured using elevated-plus maze task.
Mice generally prefer to be in the closed arms of the maze, but their
natural curiosity compels them to explore their environment. Their
level of anxiety was determined by the amount of time spent exploring
the open arms of the maze versus the time spent in the closed arms.
!
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CX3CR1

-/-

+/-

and CX3CR1

spent similar amounts of time in the open

arms and in the center zone compared to wild-type mice (data not
shown). Taken together, the absence of the CX3CR1 receptor does
not impair spontaneous locomotor activity nor cause excessive
anxiety-like behavior.
Impairment of cognitive function in CX3CR1 deficient
mice. Hippocampal-dependent associative learning and memory was
assessed in CX3CR1-/-, CX3CR1+/- and wild-type mice using contextual
fear conditioning (CFC) and cued fear conditioning. Animals were
trained with a standard two-shock protocol as previously described
(Weeber, Beffert et al. 2002). Freezing to the context (hippocampaldependent) or to the conditioned stimulus in a novel context
(hippocampal- and amygdala-dependent) was used as an index of
memory formation. During training, CX3CR1-/- and CX3CR1+/displayed similar freezing behavior compared to wild-type mice (Figure
3a). When placed in the context twenty-four hours following training,
CX3CR1-/- and CX3CR1+/- show a decrease in freezing to the context
compared to wild-type mice (Figure 3b; One-way ANOVA, Bonferroni
post-hoc = p< 0.001). Interestingly, CX3CR1+/- mice were
significantly different from the CX3CR1-/- mice, further suggesting that
the loss of one allele is sufficient to affect receptor function. When
placed in the novel environment and presented with the conditioned
!
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stimulus, there were no significant differences between CX3CR1 ,
CX3CR1+/- and wild-type mice, suggesting that the behavioral deficits
may be limited to hippocampal-dependent behaviors (Figure 3c). To
further assess hippocampal-dependent learning and memory, the
same group of mice was tested in the hidden platform water maze
(HPWM) task. There were no significant differences in escape latencies
between experimental groups during training (Figure 3d). However,
both CX3CR1 -/- and CX3CR1+/- mice had a significant decrease in the
number of target platform crossings during the probe trial compared to
wild-type mice (Figure 3e; One-way ANOVA followed by Bonferroni
post-hoc: p<0.05). No differences were observed between
experimental groups on the visible platform test (data not shown).
These data further support the role of the CX3CR1 receptor to
modulate hippocampal-dependent learning and memory.
CX3CR1 deficient mice have impaired long-term
potentiation (LTP). LTP is the most widely studied cellular model of
memory. The observation that CX3CR1 -/- and CX3CR1 +/- mice have
deficiencies in both associative and spatial memory led us to
determine whether the hippocampal-dependent memory deficits
observed in these mice correlate with a reduction in synaptic plasticity.
Both CX3CR1 -/- and CX3CR1 +/- mice showed significantly reduced
hippocampal-dependent LTP compared to wild-type controls (Figure
!
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4a-c). Interestingly, examination of basal synaptic transmission
revealed no differences between experimental groups (data not
shown), suggesting that the decrease in LTP may be due to post-high
frequency stimulation-dependent cellular mechanisms and may not
represent differences in overall synaptic transmission. Additionally,
short-term plasticity evaluated by paired-pulse facilitation (PPF) is
found to be normal in these mice, further suggesting that presynaptic
function is not affected through decreased or absent levels of CX3CR1
(Figure 4c; one-way ANOVA followed by Tukey’s post hoc: *, p<0.01).
It has been shown that hippocampal slice preparations enhance
microglial activation (Haynes, Hollopeter et al. 2006). Given the wellcharacterized effects of CX3CR1 signaling in modulating microglial
activation, it was important to examine the hippocampal slice
preparations for baseline alterations in microglial activation and/or
neurotoxicity between WT, Cx3cr1+/-, and Cx3cr1-/- genotypes. DAPI
staining showed no difference between genotype in microglia alteration
and or neurotoxicity (data not shown)
CX3CR1 deficient mice have increased microglial
activation, hippocampal levels of IL-1b and p38 and cerebellar
levels of TNFa. The IL-1 receptor antagonist, IL-1ra, is the naturally
occurring receptor antagonist of IL-1b (Dinarello 1997; Rothwell, Allan
et al. 1997). Recently, we demonstrated in young rats that infusion of
!
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IL-1ra completely reverses the decrease in hippocampal neurogenesis
induced by the co-administration of CX3CR1 blocking antibody
(Bachstetter, Morganti et al. 2009). Next, we wanted to determine if
basal levels of hippocampal IL-1b were altered in CX3CR1-/- mice.

We

analyzed the hippocampus of these mice for protein expression of IL1b.

Hippocampi from CX3CR1-/- and CX3CR1 +/- mice have increased

IL-1b expression compared to wild-type mice (Figure 5a; One-way
ANOVAs, p<0.01).
The MAP kinase p38 is a key signal transduction factor involved
in the production of IL-1b and TNFa (Guesdon, Freshney et al. 1993;
Rouse, Cohen et al. 1994; Raingeaud, Gupta et al. 1995). Due to the
importance of p38 in IL-1b signaling, we wanted to determine whether
hippocampal levels of phospho-p38 were altered in CX3CR1 deficient
mice.

Not surprisingly, phospho-p38 protein levels were significantly

increased in the hippocampus of CX3CR1-/- and CX3CR1+/- mice when
compared to wild-type mice (Figure 5b). CX3CR1-/- mice have
impaired motor learning that may represent cerebellar dysfunction.
We next determined whether deficiencies in CX3CR1 affected
cerebellar TNFa protein levels. TNFa expression was significantly
increased in CX3CR1-/- mice compared to wild-type (Fig 5c). Taken
together, CX3CR1 deficiency leads to increased expression of IL-1b,
p38 and TNFa, suggesting increased inflammation of the CNS.
!
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Loss of CX3CR1 leads to over-activation of microglia following an

insult.

To determine under basal conditions whether lack of CX3CR1

receptor leads to increased activation of microglial cells, we
immunostained hippocampal sections from CX3CR1 -/-, CX3CR1+/and wild-type mice for Iba-1, a marker for both resting and activated
microglia. The area of Iba-1 staining is significant higher in CX3CR1-/when compared to wild-type and CX3CR1+/- mice (Figure 5d, p <
0.05, CX3CR1-/- vs wild-type), reflecting an increased volume of
microglial cells reflective of morphology associated with activated
microglia.
IL-1ra recovered the LTP deficit of CX3CR1 deficient mice.
Increased levels of IL-1b negatively modulate induction and
maintenance of LTP (Cunningham, Murray et al. 1996; Kelly, Vereker
et al. 2003). Because mice lacking the CX3CR1 receptor have
increased levels of IL-1b, we determined if the IL-1 receptor
antagonist, IL-1ra, reverses the impairment in synaptic plasticity
observed in the CX3CR1-/- mice. To determine if IL-1ra can improve
synaptic plasticity in CX3CR1 deficient mice, hippocampal slices were
perfused with varying concentrations of IL-1ra and post-tetanic
potentiation was induced. In agreement with the LTP results,
hippocampal slices from CX3CR1-/- mice had deficits in PTP compared
to wild-type mice (Figure 6a). However, when hippocampal slices
!
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from CX3CR1

mice were perfused with 100 µg/ml of IL-1ra, the

deficit in PTP was rescued (Figure 6a). Blocking the function of IL-1b
completely reversed the impairment in PTP. Our observation that PTP
in hippocampal slices from CX3CR1-/- was rescued with perfusion of IL1ra prompted us to determine if the long-lasting LTP deficit in CX3CR1/-

mice could be rescued as well. Perfusion of 100 µg/ml of IL-1ra to

hippocampal slices from CX3CR1-/- completely rescued the deficit in
LTP induction and maintenance (Figure 6b). Taken together, these
results suggest that the deficits seen in CX3CR1-/- are due to increased
levels of IL-1b, further implicating a detrimental increase of
inflammation in the CNS.

IL-1ra reversed the deficit in hippocampal dependent
cognitive function but not motor learning in CX3CR1 deficient
mice. To determine whether the impairment in motor learning and
cognitive function was also dependent on IL-1b , we performed a
second study in which wild-type and CX3CR1-/- mice were infused with
either IL-1ra, heat-inactivated IL-1ra, or ACSF. In agreement with the
first study, mice were tested starting from the least invasive task
(open field) to the most invasive task; Morris water maze (McIlwain,
Merriweather et al. 2001).

!
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Open Field and Elevated Plus Maze. Although in the first study

there were no significant impairments in general locomotor activity,
explorative behavior and anxiety levels of the CX3CR1 deficient mice
and wild-type, it was crucial to retest the performance of new groups
of mice, to exclude the possibility that the surgery procedure could
impair general motor activity or enhance anxiety levels . Wild-type
mice infused with either ACSF (n = 11), heat-inactivated IL-1ra (n =
12),IL-1ra (n = 11), and CX3CR1-/- infused with either ACSF (n = 14)
or IL-1ra (n = 13) were first tested in the open field behavioral task.
Spontaneous locomotor activity was assessed as the total amount of
distance traveled in the chamber. As observed in the first study there
were no significant differences between genotypes in total distance
traveled. Furthermore, no significant differences were observed
between treatments (data not shown). In addition, the distance
traveled in the center zone compared to the perimeter zone and the
time spent in each zone was similar between groups (data not shown).
Anxiety levels were also measured using elevated-plus maze task.
Their level of anxiety was determined by the amount of time spent
exploring the open arms of the maze versus the time spent in the
closed arms. As previously shown, all groups spent similar amounts of
time in the open arms and in the center zone compared to wild-type
mice and no effect of IL-1ra was observed (data not shown).
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Rotarod. Wild-type mice (ACSF, n = 11; heat-inactivated IL-

1ra,n = 12; IL-1ra, n = 11) and CX3CR1-/- (ACSF, n = 14; IL-1ra, n =
13) were then tested on rotarod as described above. No differences
were observed between genotypes during the first day of training (Fig
7A). On the second day of training (trials 5-8), wild-type mice
remained on the rod for longer periods of time compared to CX3CR1-/mice. However, neither CX3CR1-/- treated with IL-1ra or CX3CR1-/control mice showed significantly improvement in motor coordination
on the second day of training (Figure 7a; 2-way ANOVA, trial,
p<0.0001; treatment, p<0.0001; interaction p= 0.69). As
demonstrated in the first study (Figure 2a), all wild-type mice
performed significantly better on trial 8 compared to trial 1 than did
CX3CR1-/- control group (Bonferroni posttest, WT ACSF, heat-inact.
IL-1ra, WT IL-1ra vs CX3CR1-/- p< 0.05). CX3CR1-/- IL-1ra - treated
mice motor performance was not different from CX3CR1-/- control
group (CX3CR1-/- vs CX3CR1-/- IL-1ra, p>0.05, data not shown),
suggesting that IL-1ra does not modulate the motor learning
impairment. There were no significant differences on the first trial of
testing between all experimental groups, which suggests that there is
no difference in baseline motor skills (data not shown). Taken
together, these data suggest that IL-1b does not modulate the deficits
in motor learning observed in the CX3CR1-/- mice.
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Contextual Fear Conditioning. To address the role of IL-1b in the

cognitive impairment observed in CX3CR1 deficient mice, we trained
wild-type mice (3 subgroups: ACSF, heat-inactivated IL-1ra, IL-1ra)
and CX3CR1-/- mice (2 subgroup: ACSF, IL-1ra) on contextual fear
conditioning and auditory cue fear conditioning as described above.
During training, all groups showed similar levels of freezing in
response to the first and second pairing of tone and mild foot shock
(Figure 7B). This indicates that all groups have the capability of
freezing and that the acquisition of fear memory is indistinguishable
between the two groups. When placed in the training context 24
hours following training, CX3CR1-/- mice showed a significant reduction
in the amount of freezing compared to wild-type mice (Figure 7c;
p<0.0005; Bonferroni post-hoc = WT ACSF vs CX3CR1-/- p < 0.05;
wild-type heat-inact. IL-1ra vs CX3CR1-/- p < 0.001). Interestingly,
IL-1ra completely reversed the deficit in contextual memory in
CX3CR1-/- mice (Bonferroni post-hoc = p< 0.001), suggesting that IL1b modulates the deficit in contextual memory due to the loss the loss
of CX3CR1. Wild-type mice treated with IL-1ra were not significantly
different from CX3CR1-/- control or from wild-type controls. In
contrast, all groups exhibited identical responses to the presentation of
the auditory CS when presented in a different context (data not
shown). These data suggest that IL-1b action is specific for
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hippocampal-dependent cognitive function. To control for possible
differences in response to the foot shock, a shock threshold test was
performed. No differences were observed in the perception of the foot
shock delivery as assessed by determining the stimulus amplitude
necessary to evoke a flinching, jumping, or vocalization (data not
shown).
Morris water maze. Following the observation that IL-1 directly
modulated the impairment in contextual memory in CX3CR1 deficient
mice, we sought to determine if IL-1b also modulated the deficit
previously observed in spatial learning (Figure 3). To answer this
question, 8 days following fear conditioning the same animals were
trained to locate a submerged platform in a circular pool filled with
opaque water as described in the first study, a probe trial was
performed after 9 days of training matching the data shown from
study 1. No difference was observed between groups in the latencies
to find the platform during training, indicating that all animals have
normal acquisition of spatial information (Figure 7D). We then
analyzed memory retention with a probe trial where the platform was
removed and mice were allowed to free swim. CX3CR1 -/- control mice
had a significant decrease in the number of target platform crossings
during the probe trial compared to wild-type control mice (Figure 7e;
Two-way ANOVA, P = <0.0001 followed by Bonferroni post-hoc: WT
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-/-

ACSF, WT heat-inactivated IL-1ra vs CX3CR1

control p<0.05).

Importantly IL-1ra was able to completely reverse the deficit in spatial
memory observed in CX3CR1 deficient mice (CX3CR1-/- control vs
CX3CR1-/- IL-1ra, p < 0.05). No differences were observed between
experimental groups on the visible platform test (data not shown). In
addition we analyzed the time spent in the target platform zone.
CX3CR1-/- mice spent significantly less time in the target zone
compared to wild-type control (Figure 7F, Two-way ANOVA, p<0.0001
followed by Bonferroni post-hoc: wild-type ACSF, wild-type heatinactivated IL-1ra vs CX3CR1-/- control IL-1ra p<0.05). CX3CR1-/mice treated with IL-1ra spent the same amount of time in the target
zone when compared to control (CX3CR1-/- control vs CX3CR1-/- IL-1ra
p< 0.001). No difference was observed in the number of crossing and
in the time spent in the target quadrant between CX3CR1-/- control
mice and wild type mice treated IL-1ra. These data further support
the role of the CX3CR1 receptor to modulate hippocampal-dependent
learning and memory and that IL-1β modulates the impairment in
hippocampus dependent cognitive function.

DISCUSSION

!

!

45!
For the first time the present studies test the hypothesis that

CX3CL1signaling through CX3CR1 may be necessary for normal
synaptic function. We demonstrated a physiological role of the
chemokine receptor CX3CR1 to regulate cognitive function and
synaptic plasticity. Furthermore, we show that genetic disruption of
CX3CR1 impairs hippocampal neurogenesis, motor learning,
associative memory, spatial memory, and the induction of LTP.
Importantly, these deficits appear to be gene-dose dependent and
related to increased levels of IL-1b.
These novel discoveries provide important insight to
understanding the involvement of the CX3CR1 receptor under
physiological conditions. Previously, we showed that CX3CR1-/- mice
have decrease hippocampal neurogenesis when compared to
heterozygote littermates (Bachstetter, Morganti et al. 2009). We now
demonstrate a gene-dose-dependent effect of CX3CR1 deficiency as
demonstrated by heterozygous CX3CR1 mice that exhibit an
intermediate phenotype. This effect was observed in associative and
spatial memory formation, which indicates that the loss of a single
allele is sufficient to impair the receptor function.
Recently, a gene-dose effect of CX3CR1 receptor was reported
that related to fibrillar Ab deposition in APP-PS1 mice crossed with
CX3CR1-/-, CX3CR1+/- or CX3CR1+/+ (Lee, Varvel et al. 2010).
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Reduction in fibrillar Aβ deposition in the APP-PS1 mouse model of AD
was gene-dose dependent on CX3CR1 deficiency, with CX3CR1+/- mice
displaying an intermediate phenotype. The present studies are in
agreement with those previous results and underscore the profound
implication of this discovery toward interpretation of all previous
studies using only CX3CR1-/- and CX3CR1+/- mice.
We report a novel physiological role for the CX3CR1 receptor in
the regulation of hippocampal-dependent memory formation. The
impairment of LTP and neurogenesis likely represent the mechanism
responsible for the defect observed in hippocampal-dependent
associative and spatial memory formation. However, multiple
mechanisms can account for the impairment in cognitive function and
synaptic plasticity observed in the CX3CR1-defient mice.
CX3CL1 has been implicated as a endogenous neuronal
modulator, which controls the over-production of iNOS, IL-1β, TNFα
and IL-6(Biber, Neumann et al. 2007). CX3CL1 levels are downregulated with neuronal injury, which results in microglial recruitment,
activation and increase production of TNFa, IL-1b and p38 MAP kinase.
IL-1b is a pro-inflammatory cytokine, which is constitutively expressed
in the CNS, particularly in the hippocampus, and is synthesized by
neurons and glial cells following neuronal injury (Rothwell, Allan et al.
1997; Dinarello 1998). Binding studies demonstrate that the
!

!

47!

hippocampus contains the highest density of IL-1b binding sites
(Farrar, Kilian et al. 1987; Takao, Tracey et al. 1990). These findings
suggest that the effects of IL-1β might be specific to hippocampus,
which may affect hippocampal-dependent learning and memory
processes. Furthermore, there may be a causal relationship between
the decrease of LTP and increase of IL-1β expression.
In the present study, we demonstrate that hippocampal protein
levels of IL-1b and phospho-p38 are significantly increased in mice
lacking CX3CR1 receptor. This increase was accompanied by a change
in morphology, consistent with the activation of hippocampal microglia
cells, observed as increased area of Iba-1 staining. Furthermore, the
increase of these protein levels was accompanied by a decrease in LTP
in CX3CR1 deficient mice. The deficit in LTP was gene-dose
dependent, with CX3CR1+/- mice that demonstrate an intermediate
phenotype. Importantly, both the deficits in LTP and cognitive
function were rescued with administration of IL-1ra, which blocked the
IL-1 receptor I. Under physiologic circumstances IL-1β seems to be
required for normal learning and memory processes. This assertion
derived from the observation that mice with targeted deletion of IL-1RI
exhibit impairments in memory and synaptic plasticity (Hirsch, Irikura
et al. 1996). Similarly, the administration of IL-1ra impairs fearconditioning (Pugh, Nguyen et al. 1999; Rachal Pugh, Fleshner et al.
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2001) and performance in the Morris water maze in young rats (Avital,
Goshen et al. 2003). In agreement with the literature, our results
show that wild-type mice treated with IL-1ra are not different from
CX3CR1-/- deficient mice in the response to contextual freezing and
Morris water maze task. Thus, physiologic levels of IL-1β might be
critical for normal memory formation in the hippocampus and the
increased IL-1β levels observed with age might impair hippocampaldependent learning and memory.
In addition to the impairment of memory function, CX3CR1deficient mice have impairments in motor learning. Interesting,
cerebellar levels of TNFa were significantly increased in mice lacking
CX3CR1 receptor. This result is in agreement with previous reports
that show TNFα modulates age-dependent deficits in motor learning
(Cartford, Gemma et al. 2002). Also, we demonstrate an important,
physiological role of the CX3CR1 receptor in normal memory formation
and synaptic plasticity. Furthermore, our results demonstrated that
disruption of CX3CR1 signaling triggers a downstream increase in IL1b, which appear to be the key modulator responsible for the
detrimental effect of loss of CX3CL1/CX3CR1 signaling on cognitive
function.
We clearly demonstrate that under non-pathological conditions,
disruption of CX3CL1/CX3CR1 signaling results in increased expression
!

!

49!

of IL-1b and p38, which is accompanied by the loss of synaptic
plasticity and memory formation. Furthermore, these effects appear
to be gene-dose dependent. This observation needs to be considered
when interpreting data associated with disease conditions or under
conditions where heterozygous mice were used as controls for
CX3CR1-/- mice. However, this discovery does not negate all of the
important findings to date with regard to the role of CX3CR1/CX3CL1
signaling in many disease conditions.
There is substantial literature in the area of CX3CR1/CX3CL1
signaling, yet no consensus to the role of this pathway as either
neuroprotective or neurodegenerative has been agreed upon.

In AD

mouse models, CX3CR1-/- microglia have increased phagocytosis,
which helps to clear Aβ (Lee, Varvel et al. 2010). Deletion of the
CX3CR1 gene in a triple transgenic (3xTg) mouse model of AD is
protective against neuronal loss(Fuhrmann, Bittner et al. 2010).
However, CX3CR1-deficient 3xTg mice were examined at an age prior
to the development of either extracellular Ab deposition or intracellular
microtubule-associated protein tau (MAPT) aggregation. Furthermore,
CX3CR1-/- mice crossed with the AD mouse model CRND8 had lower
brain levels of Ab40 and Ab42 and reduced amyloid deposits, which
are related to increased microglia proliferation and phagocytosis (Liu,
Lu et al. 2010). Finally, CX3CR1-/- mice crossed with mice
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overexpressing hTau have increased hyperphosphorylated tau and
increased toxicity, likely related to the increase p38 and IL-1β
(Bhaskar, Konerth et al. 2010) expression. Taken together, the
mechanisms that underlie CX3CR1 signaling which lead to
neurotoxicity remains unclear. In conclusion, this study demonstrated
that CX3CR1 receptors play a physiological role in normal
hippocampal-dependent cognitive function and synaptic plasticity. In
addition, the present study provides mechanistic links between
CX3CR1 and the release of IL-1b and phospho-p38, ultimately
implicating an increase in inflammation with the deficits observed in
synaptic plasticity and cognition.
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Figure 1. CX3CR1-/- mice show decreased hippocampal neurogenesis in a
gene-dose dependent manner (a, b). Unbiased stereology revealed a significant
decrease in the number of DCX+ cells in the SGZ of adult male CX3CR1-/- and
CX3CR1+/- mice compared to wild-type mice (p< 0.001). CX3CR1-/- were also
significantly different from CX3CR1+/- (p<0.05) (a). Quantification of the number
of cells that were proliferating during the preceeding 24 hours as determined by
the incorporation of BrdU, was significantly fewer in the CX3CR1-/- and
CX3CR1+/- mice compared to wild-type (p<0.001). CX3CR1-/- were also
significantly different from CX3CR1+/- (p<0.05) (b). Wild-type (WT, white bar),
CX3CR1+/- (gray bar), CX3CR1-/- (black bar). All data are presented as mean ±
SEM p < 0.01
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Figure 2.
CX3CR1-/- and CX3CR1+/- mice show motor learning impairment but normal
spontaneous activity (a, b, c). On the first day of training (trial 1-4) no difference
between genotypes was observed in the learning ability in the rotarod task (a).
On the second day of training (trials 5-8) as expected, wild-type mice learned the
rotarod task as demonstrated by their ability to remain on the rod for longer
periods. Neither the CX3CR1-/- nor the CX3CR1+/- mice showed significant
improvement in motor coordination with training when compared to wild-type (a;
Repeated Measure ANOVA, p<0.0001.). Wild-type (WT, white circles),
CX3CR1+/- (gray circles), CX3CR1-/- (black circles). All data are presented as
mean ± SEM p < 0.01. Comparison of the motor performance of each group of
mice on trial 1 versus trial 8, show that wild-type performed significantly better
than CX3CR1-/- and CX3CR1+/- (b; linear regression, p<0.001). CX3CR1 -/- and
CX3CR1+/- mice show normal spontaneous locomotor activity (c). Wild-type,
CX3CR1-/- and CX3CR1+/- mice do not show any difference in total distance
traveled in the open field (c). Wild-type (WT, white bar), CX3CR1+/- (gray bar),
CX3CR1-/- (black bar). All data are presented as mean ± SEM p < 0.01
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Figure 3. CX3CR1-/- mice show impairment in contextual fear conditioning and
Morris water maze memory function. CX3CR1-/- (black circles) and CX3CR1+/(gray circles) are compared to littermate wild-type mice (white circles). In panel
A, a tone (solid bar) was paired with a foot shock (arrowhead) at 2 and 4
minutes. Freezing behavior is shown on the day of training for CX3CR1-/-,
CX3CR1+/- and wild-type (a) and is comparable in all groups. CX3CR1-/-,
CX3CR1+/- showed significant reduced freezing response compared to wild-type,
when tested 24 h following training (b). CX3CR1-/-, CX3CR1+/- showed normal
freezing to cue component compared to controls (c). Asterisks represent p<0.01.
Panels d and e show the hidden platform version of Morris water maze task.
Mean latency to escape from a pool to hidden platform across training days (d).
A first probe test was performed on day 7 and a second probe test was
performed on day 11 (e) to determine the number of pseudo platform crossings
in the target quadrant (TQ) compared to the opposite quadrant (OP), the left
quadrant (LQ) and the right quadrant (RQ). Wild type (WT, white bar),
CX3CR1+/- (gray bar), CX3CR1-/- (black bar). All data are presented as mean ±
SEM p < 0.01. All data are presented as mean ± SEM p < 0.01
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Figure 4. CX3CR1 deficiency leads to impairments in LTP. LTP was induced
with HFS (2, 1 sec, 100 Hz bursts separated by 20 s; arrow) after 20 min of
baseline recording and changes in fEPSP slope are expressed as a percentage
of baseline (a). Representative fEPSP traces taken from hippocampal slices of
(left to right) wild-type, CX3CR1+/- and CX3CR1-/- mice (b). Both CX3CR1-/(black) and CX3CR1+/- (red) have deficiencies in LTP of area CA1 compared to
wild-type controls (white) (c). The last 5 min of fEPSPs slope recordings were
averaged for wild-type (n=12), CX3CR1-/- (n=10) and CX3CR1+/- (n=9) mice
(Asterisks represent p<0.05.) (d). Paired-pulse facilitation (PPF) was induced
with the use of paired- pulses given with an initial delay of 20 ms and the time to
the second pulse was increased 20 ms incrementally until a final delay of 300 ms
was reached. There was no significant PPF differences between experimental
groups. All data are presented as mean ± S.E p < 0.01
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Figure 5. CX3CR1 -/- and CX3CR1+/- show increased hippocampal protein
levels of IL-1β compared to littermate wild-type (WT) as measured by ELISA (a).
Western blot analysis of hippocampi from wild-type , CX3CR1-/- and CX3CR1+/mice shows an increase in phospho (p) p-38 protein in CX3CR1-/- and CX3CR1+/mice compared to that of wild-type (right blot in b; near-infrared image displayed
in gray scale). Relative p p-38 expression normalized to β-actin, shows the
highest expression in CX3CR1-/- and CX3CR1+/- (b). TNFα cerebellar protein
levels are significantly increased in CX3CR1-/- and CX3CR1+/- mice as compared
to wild-type mice as measured by ELISA (c). The area of Iba-1 staining is
significant higher in CX3CR1-/- when compared to wild-type and CX3CR1+/- as
measured by immunohistochemistry (d). Wild-type (WT, white bar), CX3CR1+/(gray bar), CX3CR1-/- (black bar). Representative photomicrographs of the Iba1+ cells in the dentate gyrus of wild-type (e) and CX3CR1 deficient mice (f). All
data are presented as mean ± SEM p < 0.01. Asterisk represents p < 0.05
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Figure 6. CX3CR1 deficiency leads to impairments in synaptic plasticity which
are rescued through IL-1β antagonism. PTP was induced with HFS (1 sec, 100
Hz bursts; arrow) after 1 min of baseline recording. LTP was induced with HFS
(2, 1 sec, 100 Hz bursts separated by 20 s; arrow) after 20 min of baseline
recording. Changes in fEPSP slope are expressed as a percentage of baseline
(a). The IL-1β antagonist, IL-1ra (100 µg/ml) rescues the PTP deficit (red, n=7)
in hippocampi taken from CX3CR1-/- (black, n=8) in area CA1 to levels seen in
wild-type (white, n=9). (b.) The LTP deficit seen in hippocampi taken from
CX3CR1-/- (black, n=10) mice is rescued with the IL-1β antagonist IL-1ra (100
µg/ml) (red, n=11).
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Figure 7. IL-1ra reversed the deficit in contextual fear conditioning and Morris
water maze memory function induced by the loss of CX3CR1 but not the deficit in
motor learning. CX3CR1-/- ACSF(blue square) and CX3CR1-/- IL-1ra - treated
mice (red square) are compared to wild-type ACSF (open circles), wild-type
treated with heat-inactivated IL-1ra (black square), and wild-type IL-1ra-treated
mice (green squares). Panel A shows that on the first day of training (trial 1-4)
no difference between groups was observed in the learning ability on the rotarod
task (a). On the second day of training (trials 5-8) all wild-type mice groups
learned the rotarod task as demonstrated by their ability to remain on the rod for
longer periods. Neither the CX3CR1-/- ACSF nor the CX3CR1-/- IL-1ra treated
mice showed significant improvement in motor coordination with training when
compared to wild-type (a);. In panel B, a tone (solid bar) was paired with a foot
shock (arrowhead) at 2 and 4 minutes. Freezing behavior is shown on the day
of training for CX3CR1-/- ACSF (blue square), CX3CR1-/- IL-1ra – treated mice
(red square), wild-type ACSF (white circles), wild-type treated with heatinactivated IL-1ra (black square), and wild-type IL-1ra treated mice (green
square) and is comparable in all groups. CX3CR1-/- control mice showed
significantly reduced freezing compared to all wild-type groups, when tested 24 h
following training (c). CX3CR1-/- treated with IL-1ra (red square) showed a
freezing response similar to wild type groups. Panels d and e and f show the
hidden platform version of Morris water maze task. Mean latency to escape
from a pool to hidden platform across training days (d). A probe test was
performed on day 10 to determine the number of pseudo platform crossings in
the target quadrant (TQ) compared to the opposite quadrant (OP) (e). Wild type
ACSF (WT, white bar), wild-type treated with heat-inactivated IL-1ra (light gray
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-/bar), wild-type treated with IL-1ra (dark gray bar), CX3CR1 ACSF (black bar),
CX3CR1-/- IL-1ra – treated mice (black/white grid bar). Panel F shows the time
spent in the target platform zone. CX3CR1-/- ACSF (black bar) mice spent
significantly less time in the target zone compared to wild-type controls (wild-type
ACSF (white bar), wild-type heat-inactivated IL-1ra (light gray bar), wild-type IL1ra (dark gray bar). CX3CR1-/- mice treated with IL-1ra spent the same amount
of time in the target quadrant when compared to wild-type controls. All data are
presented as mean ± SEM p < 0.01. All data are presented as mean ± SEM p <
0.01 Asterisk represents p < 0.05: CX3CR1-/- control vs wild-type controls; ##
represents p<0.001: CX3CR1-/- IL-1ra vs CX3CR1 -/-.
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Abstract
Chronic neuroinflammation is characterized by activation of the
innate immune system and it is an important element common to
many neurological and pathological conditions associated with memory
loss and cognitive dysfunctions. Activated microglia and their products
are key mediators of neuroinflammation and contribute to neuronal
damage. Neuroinflammation can be reproduced by chronically infusing
lipopolysaccharide (LPS) into the 4 ventricle of rats resulting in region
th
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selective microglia activation in the hippocampus, and impaired
hippocampal dependent functions. Recent findings indicate that
neurons are not passive targets, but rather control microglial activity
and modulate neuron-glia communications. The chemokine fractalkine
(CX3CL1) is a neuronally derived signal that has been shown to
regulate the neurotoxic effects of microglia though its receptor
CX3CR1. We recently demonstrated that CX3CR1 has a physiological
role in normal hippocampal-dependent cognitive function and synaptic
plasticity. Disruption of CX3CL1-CX3CR1 signaling has been shown to
exacerbate neurotoxicity in animal models of many neuropathological
disorders including AD. In the present study we investigated if chronic
inflammation alters neuron to microglia signaling via the CX3CL1CX3CR1 signaling pathway. Rats were chronically infused for 28 days
with LPS (0.25ug/h) or artificial cerebrospinal fluid (aCSF). On day 31
animals were tested for spatial and object recognition memory. LPSinduced chronic neuroinflammation resulted in impairment of novel
place recognition but not of novel object recognition memory. Analysis
of hippocampus protein lysates revealed a significant reduction in the
amount of CX3CR1 protein levels in LPS infused animals compared to
aCSF controls with no significant changes in CX3CL1 levels. The LPSinduced reduction in hippocampal CX3CR1 paralleled a significant
induction of classical microglial activation markers TNF-α, Notch1, NF!
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kB p65 as well as the co-receptor for LPS; TLR4. Together these
studies demonstrate that altered microglia signaling through CX3CL1CX3CR1 is involved in the modulation of LPS-induced chronic
neuroinflammation in the hippocampus. The CX3CL1-CX3CR1 signaling
pathway may mediate the altered coupling of neuronal activity with
macromolecular synthesis implicated in plasticity and memory during
LPS-induced neuroinflammation.

Introduction
Numerous neuropathology and in vivo clinical imaging studies
suggest that activated microglia play a prominent role in the
pathogenesis of several neurodegenerative disorders such as
Alzheimer’s disease (AD), Parkinson disease and immune mediated
neurological disorders (HIV) (McGeer and McGeer 1998; Cagnin,
Brooks et al. 2001; Garden, Guo et al. 2004). Microglial cells are the
resident innate immune effectors of the brain and react to various
"insults", such as abnormally aggregated proteins, viruses, bacteria,
physical injury or signaling molecules released by neurons though
activation of Toll-like receptors (TLRs). Activated microglia are a
prominent source of pro-inflammatory cytokines, chemokines, reactive
oxygen species and complement proteins (Mantovani, Sica et al. 2004;
Mosser and Zhang 2008; Cameron and Landreth 2010). While
microglia activation is normally adaptative, uncontrolled and over!
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activated microglia can lead to bystander damage to neurons.
Chronically activated microglia and their products are key mediators of
the neuroinflammatory cascade, which may lead to neuronal
dysfunction (Barger and Basile 2001).
Recent data has begun to establish CX3C- chemokine fractalkine
(CX3CL1) to fractalkine receptor (CX3CR1) interactions as an
important mechanism of microglial regulation, hippocampal functions
and synaptic plasticity (Harrison, Jiang et al. 1998; Mizutani, Sakurai
et al. 2007; Bachstetter, Morganti et al. 2009; Wynne, Henry et al.
2010; Pabon, Bachstetter et al. 2011; Rogers, Morganti et al. 2011).
CX3CL1 is constitutively expressed by neurons in the CNS with
CX3CR1 found solely on microglia (Harrison, Jiang et al. 1998;
Maciejewski-Lenoir, Chen et al. 1999; Boehme, Lio et al. 2000;
Cardona, Pioro et al. 2006). This signaling pair presents the unique
ability for neurons to directly interact with microglia. In vivo
neutralization of endogenous brain CX3CL1 increases hippocampal
Tumor Necrosis Factor (TNF)-〈 induced by intracerebroventricular
(i.c.v.) injection of lipopolysaccharide (LPS) (Zujovic, Schussler et al.
2001) and CX3CR1-deficiency amplifies microglial IL-1ß expression,
neurotoxicity, and mortality following peripheral LPS injections
(Cardona, Pioro et al. 2006). Though CX3CL1-CX3CR1 likely
represents a critical element of microglia regulation, little is known
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about how this pathway is altered during chronic neuroninflammation.
In the present study, we aimed to assess to what extent CX3CL1
and CX3CR1 expressions were impacted in a well-established rodent
model of LPS-induced chronic neuroinflammation. We demonstrate
that at a time point where spatial cognitive function is impaired,
CX3CR1 but not CX3CL1 expression level was significantly decreased
in the hippocampus. This decrease was closely associated with
markers of classical microglia activation and occurred only in the
hippocampus but not in the prefrontal cortex.
Materials and Methods
Animal procedures. This research was conducted under the
supervision and with the approval of the University of California
Institutional Animal Care and Use Committee. Twelve 3-month-old
male F344 rats (Charles River Labs) living in an inverted 12-hour
light/dark cycle (lights off at 8 a.m. and on at 8 p.m.) were individually
caged with food and water freely available. Surgeries were performed
as previously described in details (Rosi, Ramirez-Amaya et al. 2005).
Artificial cerebrospinal fluid (aCSF; n=6) or lipopolysaccharide (LPS;
n=6; Sigma-Aldrich, E.coli, serotype 055:B5, TCA extraction, 1.0 µg/µl
dissolved in aCSF) were loaded into an osmotic pump (Alzet pump
model 2004; to deliver 0.25 ul/h; 28-day delivery; Durect corporation)
and chronically infused for 28 days through a cannula implanted into
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the fourth ventricle of the brain as described previously (Rosi,
Ramirez-Amaya et al. 2005).
Behavioral testing. The rats were handled daily for 10 days
before behavioral testing began and behavioral manipulations were
carried during the dark phase. A 60 cm square open field plastic arena
was placed in a dim lit dedicated behavioral testing room. Various
large extramaze spatial cues were placed on the walls of the testing
rooms. Three sets of objects (A, B and C,) were used (Fig. 8). Small
pieces of white Velcro placed on the undersides of the objects and on
the arena floor were used to secure the objects in place during testing.
Arenas and objects were cleaned with diluted bleach between trials to
minimize odor cues. The procedure began with 2 days of habituation,
during which rats were allowed to explore the open field arena for
15 min. On day three, two similar objects A were placed in opposite
corners of the box, and the rats were allowed to explore the objects
for 5 min. The rats were removed from the box for 5 min, and for the
5 min retention novel place recognition (NPR) test, one of the objects
was moved to a new open corner (target object), and the rats were
allowed to explore for 5 min. On day 4, a 24 h retention NPR test was
conducted. The target object was moved to the remaining open corner
and the rats were allowed to explore for another 5 min. For the novel
object recognition (NOR) task, two objects B were placed in the
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corners not used for the 24h NPR test, and the rats were allowed to
explore the objects for 5 min. The rats were again removed from the
box for 5 min, and one of the objects was replaced with a novel object
C (target object), and the rats were allowed to explore for another
5 min. An overhead camera recorded the trials and live tracking of the
animals was achieved using an automated video tracking system that
discriminates tail to nose recognition (Ethovision XT; Noldus
Information Technology). Exploratory behavior defined as the animal
directing its nose toward an object at a distance within a 4-cm radius
was analyzed during the first 30 sec on each test. Data are expressed
as the percent time spent exploring the target object ([time exploring
target]/[time exploring target + time exploring non-target object] x
100), where the re-located object during the place recognition task
and the novel object during the object recognition task represent the
target object.
Brain Extractions and Protein Analysis. Animals were
euthanized by deep isoflurane anesthesia followed by decapitation, the
brain were quickly removed and the hippocampus and prefrontal
cortex dissected and immediately frozen in -70 °C isopentane (SigmaAldrich) for protein extraction. Hippocampal and cortical tissues from
one brain hemisphere were homogenized using an electric tissue
homogenizer in 1:10 weight to volume ratio of ice-cold RIPA buffer
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(Millipore) containing protease inhibitors and EDTA (Pierce). Following
homogenization, sample lysates were centrifuged at 10,000 x g at 4ºC
for 15 minutes, the cleared supernatant was collected. Total protein
content was measured using standard BCA assay (Pierce). For Western
blot Analysis; 50 µg of total protein per lane was loaded onto a 10%
SDS-polyacrylamide gel for electrophoresis. Proteins were transferred
onto a nitrocellulose membrane for immunodetection. The membrane
was blocked for 1-hour in 5% NFDM in PBS-Tween20 (PBST, 0.1%).
Primary antibody incubations for CX3CR1 (Abcam, 1:1000), TLR4
(Abcam 1:1000), NF-kBp65 (AbCam; 1:500), Notch1 (Invitrogen;
1:1000), and Actin (Sigma; 1:3000) occurred overnight at 4ºC in 1%
NFDM in PBST. Following washes in PBST, membranes were incubated
simulateneously with anti-rabbit and anti-mouse secondary antibodies
(LiCor; 1:5000) for 1-hour at room temperature in 1% NFDM in PBST.
Following washes in PBST, membranes were scanned using LiCor
Odyssey scanner and intensity for each band was measured using
LiCor Odyssey image analysis software. For ELISA analyses, total
CX3CL1 and TNF-〈 were assayed following manufacturer’s suggested
protocol (RayBiotech; Norcross, GA).

Statistical Analysis. Statistical analysis was performed with the
GraphPad Prism software version 5.0, using the Student’s t-test or
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one-way ANOVA followed by a post-hoc Newman-Keuls multiple
comparison test. Results are expressed as mean ± SEM and p<0.05 is
considered significant for all tests.

Results
Chronic LPS-infusion impairs spatial recognition but not
objects recognition memory. Hippocampal-dependent spatial
recognition memory was tested with the novel place recognition (NPR)
test with 5min and 24h delay. Low dose LPS infusion did not impair
mobility, as both aCSF and LPS infused rats explored similarly (Fig. 9a)
In the 5 min retention NPR test (Fig. 9b), the control aCSF-infused rats
spent a higher percent time exploring the object in the novel location
than the one in the familiar location (64.71 ± 9.21 %; p=0.04). In
contrast, LPS-infused animals spent a similar time exploring the object
that had changed position (45.57 ± 9.39) and the object that had
remained in a constant position (p=0.52). Similar observation were
made in the 24 h retention NPR test (Fig. 9c), where aCSF-infused rats
spent a significantly higher percentage of time exploring the object in
the novel location (75.16 ± 12.39 %) than that in the familiar location
(p=0.01) whereas LPS-infused animals did not (55.40 ± 14.01 %;
p=0.59). Recognition memory for objects, known not to depend
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strictly on the hippocampus (Mumby, Gaskin et al. 2002), was
measured with novel object recognition test (NOR). In the NOR test,
both aCSF- and LPS-infused rats showed significant discrimination
between the novel and familiar objects (Fig. 9d), spending significantly
a higher percentage of time exploring the novel than the familiar
object (92.82 ± 3.864 and 89.75 ± 4.511, respectively; p<0.0001 vs.
familiar object for both).
Chronic LPS-infusion results in decreased CX3CR1 levels
and increased classical activation of microglia markers in the
hippocampus. As the CX3CL1 signaling axis has been implicated in
attenuating the pro-inflammatory response following exposure to LPS,
we examined how the protein levels of both CX3CL1 and CX3CR1 were
affected in response to chronic i.c.v. infusion of LPS. Chronic i.c.v.
infusion of low doses of LPS for 28 days resulted in a significant
decrease in CX3CR1 protein levels in the hippocampus compared to
aCSF-infused animals (Fig. 10a; p=0.006). Regardless of the
treatment, aCSF or LPS, the total CX3CL1 (soluble and membrane)
levels remained unchanged (Fig. 10c). Interestingly, the reduction on
CX3CR1 was observed only in the hippocampus but not the prefrontal
cortex (Fig. 10d). Chronic LPS-infusion resulted in a significant upregulation of the proinflammatory cytokine TNF-〈 in the hippocampus
(p=.004, Fig. 11a) but not in the prefrontal cortex (Fig. 11b).
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Furthermore, Notch1 a marker for classical activation in microglia, was
significantly up-regulated in lysate from hippocampal (p=.0008, Fig.
11c) but not prefrontal cortical (Fig. 11d) tissue. Exposure to chronic
i.c.v. low doses of LPS also upregulated the production of LPS
coreceptor TLR4 in the hippocampus compared to infusion with aCSF
(p=0.01) but no difference was observed in PFC (Fig 12a, b). A similar
change, after chronic LPS-infusion, was observed with the intracellular
transcription factor Nuclear Factor kappa B, only in the hippocampus
(NF-%B p65, p=0.005; Fig. 12c, d).

Discussion
In the present study we demonstrated that during chronic
neuroinflammation there is a significant reduction in the microglial
fractalkine receptor CX3CR1 in the hippocampus. These changes are
paralleled by classical activation of microglia only in the hippocampus
and impaired spatial dependent recognition memory. To the authors’
best knowledge this is the first report of alterations in the protein
levels of CX3CR1 in the hippocampus under chronic neuroinflammatory
conditions.
Fractalkine is a unique chemokine that plays an important role in
mediating neural–microglial interaction. A balanced signaling in the
CX3CL1 to CX3CR1 pathway is necessary to keep microglia in a non!
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inflammatory state (Cardona, Pioro et al.). Inhibition of CX3CR1 has
been shown to increase microglia activation and production of
proinflammatory cytokines in CX3CR1 deficient mice (Cardona, Pioro et
al. ; Bachstetter, Morganti et al.). CX3CL1 to CX3CR1 ligation acts as
an endogenous calming signal for microglia and disruption of this
pathway is exacerbates in multiple pathological models (Bhaskar,
Konerth et al.), and in humans (Combadière, Feumi et al.).
Administration of exogenous CX3CL1 has been shown to reduce the
LPS-induced production of pro-inflammatory cytokines (IL-1β, IL-6,
TNF〈) and nitric oxide in vitro, as well as preventing cytokine induced
neuronal cell death (Zujovic, Benavides et al. 2000; Zujovic, Schussler
et al. 2001; Mizuno, Kawanokuchi et al. 2003). Given the antiinflammatory capabilities of CX3CL1 in an LPS model of inflammation,
we investigated if chronic exposure to LPS affected CX3CL1-CX3CR1
signaling. Here we show that during chronic neuroinflammation, while
the level of the CX3CL1 remains unchanged regardless of the brain
region the microglial CX3CR1 levels are reduced only in the
hippocampus. These data corroborate a previous report wherein acute
peripheral administration of LPS in mice does not alter the
hippocampal levels of CX3CL1 (Wynne, Henry et al.). The reduced
levels of CX3CR1 found in this study were paralleled by increased in
the proinflammatory cytokine TNF-alpha. These data are in agreement
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with previous data showing that CX3CR1 KO mice showed elevated
levels of proinflammatory cytokines (Rogers, Morganti et al. 2011)
however it remains unclear whether the increases in TNF could drive
the changes in CX3CR1 or vice versa. Furthermore, these data
corroborate findings where LPS reduced CX3CR1 both transcript and
surface expression levels from isolated microglia (Kremlev and Palmer
; Wynne, Henry et al.).
Animals infused with LPS performed significantly worse than
animals infused with aCSF in NPR. Interestingly, no impairment was
observed in NOR task regardless of either infusion, as both treatments
displayed significant preference for NO. The spatial dependent
recognition memory task is primarily hippocampal dependent (Morris,
Garrud et al. 1982; Mumby, Gaskin et al. 2002; Barker and Warburton
2011), while the object recognition memory test does not rely
principally in hippocampal functioning (Aggleton and Brown 1999;
Mumby, Gaskin et al. 2002). Interestingly, the lack of impairment in
NOR is associated also with the lack of inflammatory induction
detected in tissue outside the hippocampus. These data show that the
hippocampus is the most vulnerable region to LPS-insult. The high
vulnerability of the hippocampus versus other brain regions could be
due to different reasons. Given that LPS acts through microglia TLR4
receptors it could be either that the distribution of TLR4 in the
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hippocampus is more concentrated or that once initiated, the
inflammatory process in the hippocampus cannot resolve with time.
The CX3CL1 signaling axis has been shown to modulate glutamitergic
signaling (Deiva, Geeraerts et al. 2004), it is possible that the
reduction in CX3CR1 protein alters this function, which results in
neuronal dysfunction.
The LPS co-receptor TLR4, was markedly increased in the
hippocampus of LPS-infused animals but not the PFC. Further
suggesting that given a general insult, such as i.c.v. LPS infusion, the
hippocampus is the most sensitive region. Accordingly, recent work
has shown that TLR4 is upregulated in the hippocampus of patients
with AD (Walter, Letiembre et al. 2007; Letiembre, Liu et al. 2009).
Additionally, LPS-infusion induced the classical activation of microglia,
in that we saw an increased expression of pro-inflammatory molecules
in LPS-infused rats compared to those that received aCSF. LPS-infused
animals showed a marked induction of Notch1, NFkB, and TNF〈. LPS
has been previously shown to induce the expression of NFkB (Rosi,
Ramirez-Amaya et al.). Further, multiple studies have linked the
increase expression and nuclear translocation of NFkB with the Notch1
signaling pathway (Monsalve, Ruiz-García et al. 2009; Morga, MouadAmazzal et al. 2009). It is important to note that a previous report
indicated that antibody blockade of Notch1 receptor had little effect on
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LPS-induced TNF〈 production (Cao, Lu et al. 2008). Conversely, this
study only examined the effect of acute LPS exposure, while another
study has implicated exposure of TNF〈 in the induction of Notch1
receptor expression in microglia (Grandbarbe, Michelucci et al. 2007).
Notch1 signaling may indirectly participate with the induction of TNF〈
in response to chronic exposure to LPS. Our data are consistent with
these pathways being at least indirectly involved in chronic LPS
induced inflammation that results in hippocampal dependent cognitive
deficits. Taken together, it is plausible that the chronic i.c.v LPS
exposure induction of Notch1 results in increased NFkB
phosphorylation and translocation to the nucleus, which in turn
mediates TNF gene expression.
These data further support the strong correlation between the
presence of inflammation and altered neuronal function. As we
observed a distinct hippocampal related cognitive impairment as a
result from our experimental paradigm, we sought to identify key
mediators that may contribute to this cognitive dysfunction. We have
previously shown that LPS-infusion into the fourth ventricle induces
MHC II reactive microglia in the hippocampus of young rats (Rosi,
Ramirez-Amaya et al. 2005; Rosi, Vazdarjanova et al. 2006) and
impair learning and memory functions. Here we demonstrated that the
presence of inflammatory markers solely in the hippocampus is also
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associated with strictly hippocampal dependent cognitive dysfunctions.
We have previously demonstrated that under non-pathological
conditions, disruption of CX3CL1 signaling pathway leads not only to
an increased basal inflammatory profile, but also negatively alters
cognitive function (Rogers, Morganti et al. 2011). As such, it is
therefore conceivable to hypothesize that altered neuron-to microglia
signaling could contribute to the altered cognitive functions observed
in chronic inflammatory conditions as well.
As the CX3CL1-CX3CR1 signaling pair work in tandem to reduce the
production of pro-inflammatory mediators, it is plausible that
prolonged disruption of this capability may exacerbate or perpetuate
the LPS-induced chronic neuroinflammatory condition. Although others
have reported mixed results regarding the neuroprotective (Cardona,
Pioro et al. ; Bhaskar, Konerth et al. ; Pabon, Bachstetter et al.) or
neurodegenerative (Fuhrmann, Bittner et al. 2010; Liu, Lu et al. 2010;
Shan, Hong-Min et al.) functions of CX3CL1-CX3CR1 signaling, such
discrepancies may be difficult to resolve, as the role for this signaling
pair may be dependent upon the neuropathological model examined
and aspects of microglial function such as phagocytic activity versus
production of pro-inflammatory cytokines.
Our results suggest that during chronic inflammatory conditions
when hippocampal functions are compromised and microglial cells
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activated the altered neuron to microglia crosstalk could be
responsible for the cognitive functions observed. These results further
extend our understanding of the mechanisms by which chronic
neuroinflammation might contribute to the progression of cognitive
dysfunctions.
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Figure 8. Behavioral paradigm for NPR and NOR.
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Figure 9. During the familiarization phase of the NP recognition
test, both LPS and aCSF-infused animals explored similarly (A).
Animals infused with artificial cerebrospinal fluid showed novel
place recognition (70% exploration time; *p<0.05, vs. familiar
place), whereas animals infused with LPS did not (50.9%
exploration time) (B,C). Both aCSF and LPS-infused rats were
able to discriminate between two object and showed novel
object preference vs. familiar object (90 % exploration time,
***p<0.001 vs. familiar object) (D). Taken together these data
indicate that chronic LPS-infusion results in an hippocampaldependent cognitive impairment (NPR) but does not affect
hippocampal-independent cognitive functions (NOR).
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Figure 10. Chronic LPS-infusion disrupts FKN-CX3CR1 signaling
the hippocampus but not the prefrontal cortex. (A) In the
hippocamous we observed a significant decrease (p=.006) in
the protein levels of CX3CR1, but not in the prefrontal cortex
(B). Interestingly, when we examined the same tissue lysate for
these regions, total CX3CL1 (soluble and membrane) was not
altered by LPS infusion (C, D).
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Figure 11. Chronic infusion with LPS for 28 resulted in
significant up regulation of classical activation markers for
microglia. (A) In the hippocampus we observed a significant
induction (p=.004) of the proinflammatory cytokine TNF-〈 but
not in the prefrontal cortex (B). Similarly, Notch1 was
significantly upregulated (p=.0008) as a result of chronic LPS
infusion in the hippocampus but not the prefrontal cortex (D).

!
!

80!

Hippocampus

Cortex

A

B

C

D

Figure 12. Chronic LPS upregulates downstream effectors
associated with inflammation. (A) Following 28 days of
exposure to low dose LPS, the hippocampus, but not the
prefrontal cortex (B) had significant upregulation (p=.01) of the
co-receptor for LPS; TLR4. Similarly, there was a significant
change (p=.005) in the activated form of the nuclear
transcription factor NFkB p65 in the hippocampus (C) but not
the prefrontal cortex (D).
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Abstract
The exact roles for the two types of endogenous CX3CL1 in
neurodegenerative pathophysiology remain elusive. Recent literature
suggests an anti-inflammatory and thus neuroprotective role for
supraphysiological levels of exogenous CX3CL1 peptide. However, it
has been difficult to delineate the function of the soluble and
!
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membrane-bound forms of CX3CL1, as both are natively present in the
brain. As such we sought to examine each form’s ability to regulate
neuroinflammation in a mouse model of Parkinson’s disease initiated

!

by the neurotoxin 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine

(MPTP). We were able to delineate the function of both CX3CL1 forms
by using AAV mediated gene therapy to selectively express synthetic
variants of CX3CL1 that remain permanently soluble or membrane
bound. In the present study we injected each CX3CL1 variant and a
GFP expressing vector directly into the substantia nigra of CX3CL1

-/-

mice. Our results show for the first time that only the soluble form of
CX3CL1 is sufficient for neuroprotection in light of exposure to MPTP.
Specifically, we show that the soluble CX3CL1 form reduces
impairment of motor coordination, prevents exacerbation of DA neuron
loss, ameliorates microglia activation and proinflammatory cytokine
release, resulting from MPTP exposure. Furthermore, the membranebound form exacerbates MPTP induced pathologies.
Introduction
Parkinson’s disease (PD) is the third most prevalent
neurodegenerative disorder among the aging population (Smeyne and
Jackson-Lewis ; Przedborski). PD occurs sporadically with unknown
etiology but presents key characteristics affecting the motor system,
most notably resting tremor and akinesia (Bezard and Przedborski). A
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key hallmark of PD is the dramatic depletion of dopamine (DA)
through degeneration of DA neurons in the nigrostriatal neural
network. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) has
been reliably used to induce DA cell loss in the nigrostriatal pathway of
mice and non-human primates akin to what is observed in human
condition (Przedborski, Jackson-Lewis et al.). Administration of MPTP
in mice provokes neurodegeneration through both oxidative and
cytotoxic methods, specifically through disruption of mitochondrial
function and induction of microglial inflammatory mediators,
respectively. An increasing amount of evidence has emerged to
suggest that microglial activation is a key component contributing to
nigrostriatal pathway degeneration and accelerating the progression of
pathology in PD (Wu, Jackson-Lewis et al. ; Tieu, Ischiropoulos et al. ;
Cardona, Pioro et al. ; Kim and Joh ; Yasuda, Shimoda et al.).
Specifically, chronic activation of microglia results in the over
production of pro-inflammatory cytokines and chemokines, as well as
oxidative molecules leading to a neurotoxic microenvironment
(Mantovani, Sica et al. 2004; Mosser and Edwards 2008; Cameron and
Landreth 2010).
As aberrant microglia activation has been routinely shown to
contribute to the pathogenesis of PD, it is relevant to examine
endogenous mechanisms that control neuronal-glia interactions, as
!

!

84!

this is one way that neurons can signal inflammatory cells when a
response is needed. Under resting conditions there are several
neuronal mediated signals that have an anti-inflammatory action at
microglia. One of high interest in the literature is fractalkine
(CX3CL1). CX3CL1 is a chemokine expressed constitutively by healthy
neurons and it has been identified as a novel neuroimmune regulatory
protein, whose function is to send alert signals to microglia, and inhibit
microglia activity under inflammatory conditions (Harrison, Jiang et al.
1998; Ransohoff, Liu et al. 2007). Several studies have suggested a
continuous dialog between neurons and microglia under basal
conditions via CX3CL1 and its receptor (CX3CR1) (Harrison, Jiang et
al. 1998). Interaction between CX3CL1 and CX3CR1 contributes to
maintain microglia in a resting phase. Disruption of this dialog could
trigger changes in the functional phenotype of microglia. Accordingly,
recent reports have begun to characterize CX3CL1-CX3CR1
interactions as an important mechanism of microglial regulation
(Harrison, Jiang et al. 1998; Mizutani, Sakurai et al. 2007;
Bachstetter, Morganti et al. 2009; Wynne, Henry et al. 2010; Pabon,
Bachstetter et al. 2011). Constitutive neuronal expression of CX3CL1
produces a transmembrane anchored signaling subtype that can be
targeted for proteolytic cleavage by either ADAM10/17 resulting in a
soluble subtype, both of which have been shown to possess signaling
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capabilities by ligating to CX3CR1 (Chapman, Moores et al. 2000;
Garton, Gough et al. 2001; Ré and Przedborski 2006; Hundhausen,
Schulte et al. 2007; Ludwig and Weber 2007). Functionally, the soluble
subtype of CX3CL1 ligation to its receptor has been shown to inhibit
microglial activation by down regulating the production of cytotoxic
mediators (TNFα, IL-1β, iNOS, and IL-6) through p38, NFkB, and PI3K
transduction pathways (Harrison, Jiang et al. 1998; MaciejewskiLenoir, Chen et al. 1999; Garcia, Xia et al. 2000; Ré and Przedborski
2006; Ransohoff, Liu et al. 2007). Recently there has been much work
to understand the role that neuron-glia signaling may have in various
neurodegenerative models, specifically with the CX3CL1-CX3CR1
signaling axis(Duan, Yang et al. 2008; Bhaskar, Konerth et al. 2010;
Fuhrmann, Bittner et al. 2010; Lee, Varvel et al. 2010; Liu, Lu et al.
2010; Cho, Sun et al. 2011; Pabon, Bachstetter et al. 2011; Shan,
Hong-Min et al. 2011). Consequently, the current literature has yet to
define a clear role for this signaling system in neurodegenerative
animal models. Furthermore, the physiological roles of each subtype of
CX3CL1 are not completely established in the periphery or in the CNS
and there is considerable controversy as to the benefit or harm of
CX3CL1 ligation to CX3CR1. It has been shown that the membrane
bound subtype plays a role in endothelial cell death(Yoneda, Imai et al.
2003) whereas soluble CX3CL1 has been shown to be both
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neuroprotective(Pabon, Bachstetter et al. 2011) and
neurodegenerative(Shan, Hong-Min et al. 2011) in PD. To this end we
sought to examine the signaling role of the membrane bound and
soluble subtypes of CX3CL1 in an MPTP mouse model of PD.
In the present study we investigated the effects of each CX3CL1
subtype, independently (membrane bound versus soluble) expressed
in the substantia nigra of CX3CL1 null mice exposed to MPTP. We have
constructed two recombinant adeno-associated viruses (rAAVs) that
selectively express soluble CX3CL1 or a mutant form, which is
proteolytically resistant to cleavage and remains permanently
membrane bound. rAAV9 vectors were chosen as the delivery serotype
due to its specificity and high expression efficiency in neuronal cells.
We observed significant reduction in neurotoxicity in MPTP exposed
animals expressing the soluble CX3CL1 compared to those expressing
the membrane version or control vector.

Methods
AAV production. rAAV9 expressing the two different forms of
fractalkine (GI:114431260) were cloned using PCR from mouse brain
cDNA. The soluble form (sFKN; αα 1-336) was generated with primers
Frac5’ (GAGACCGGTCCACCATGGCTCCCTCGCCGCTCGCG) and Frac3’
(CTCGCTAGCTCACATGGCATAGTCAGGCACGTCATAAGGATAGCTAGAAG
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CCATTGTGGCTGCCTGGGTGTCGGGGAC). The mutant membrane
bound form (mCX3CL1; mutations to stop ADAM10/17 cleavage into
the soluble form, R337A+R338A) was generated by cloning two PCR
fragments with primers Frac5’ + Fracma
(GTAGCCCCACTGCCTGGGCAGCTGTGGCTGCCTGGGTG) and Frac3’
(CTCGCTAGCTCACATGGCATAGTCAGGCACGTCATAAGGATAGCTAGAAG
CCATCACTGGCACCAGGACGTATGAGTTAC) and Fracms
(CACCCAGGCAGCCACAGCTGCCCAGGCAGTGGGGCTAC). sFKN and
mFKN were cloned into the pTR2-MCS at the Age I and Nhe I cloning
sites. This vector contains the AAV2 terminal repeats and the hybrid
CMV-chicken β-actin promoter for CX3CL1 mRNA transcription. An HAtag was added to the C-terminus of both sFKN and mFKN with the PCR
primers. Recombinant AAV serotype 9 (rAAV9) vectors were generated
and purified as previously described (Carty, Lee et al.). rAAV particles
are expressed as vector genomes (v/g)/ml. Vector genomes were
quantitated using a modified version of the dot plot protocol described
by(Zolotukhin, Potter et al. 2002). The protocol was modified to use a
non-radioactive biotinylated probe for fractalkine generated by PCR.
Bound biotinylated probe was detected with IRDye 800CW (Li-Cor
Biosciences, Lincoln, NE) and quantitated on the Li-Cor Odyssey. UF11
plasmid was used to generate rAAV9 as described previously (Carty,
Nash et al.).
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In vitro cell culture experiments. sFKN conditioned media was

generated by transfection of HEK293 with lipofectamine 2000
(Invitrogen) and the pTR-sFKN plasmid. Cells were incubated in OptiMem (Invitrogen; containing 100U/mL penicillin and 100ug/mL
streptomycin) for 48hrs. Following incubation, medium was harvested
and cleared by centrifugation at 2000 x g. The cleared sFKN
conditioned medium was used for the proceeding cell culture
experiment. BV2 cells were seeded at 5x10 cells per well in a 24 well
5

plate in Opti-Mem (Invitrogen; supplemented containing 100U/mL
penicillin and 100ug/mL streptomycin) and allowed to adhere for 16hr.
Immediately prior to treatment, cells were washed with fresh medium
to remove any dead or non-adhered cells. Cells were treated with
conditioned media; conditioned media + LPS; LPS; or media alone for
4 hrs. Following incubation, media was removed from each of the four
groups and analyzed for TNFα using a commercial ELISA kit (RnD
Systems; Minneapolis, MN) following manufacturer’s protocol.
Animals: All experiments were conducted in accordance with the
National Institute of Health Guide and Use of Laboratory Animals, and
were approved by the Institutional Animal Care and Use Committee of
the University of South Florida, College of Medicine or the University of
Florida, as appropriate. CX3CL1 mice (Merck) were backcrossed to
-/-

the C57BL/6J (WT) background (Jackson Laboratories; Barharbor,
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Maine) for greater than 10 generations. Colonies of C57BL/6 and
CX3CL1 littermates were maintained at the University of South
-/-

Florida and genotyping was outsourced using a commercially available
service (Transnetyx; Cordova, TN). 12 to 16 week old C57BL/6 and
CX3CL1 littermates were used in the experiments. Mice were pair-/-

housed in environmentally controlled conditions (12:12 h light:dark
cycle at 21 ± 1°C) and provided food and water ad libitum.
Surgical procedure. Mice for the treatment groups were
randomly selected and age stratified to ensure equal representation.
Three groups of 12-16 week old male CX3CL1 mice (n=30 per group)
-/-

were injected with membrane-bound (mFKN), soluble (sFKN), or rAAVGFP (GFP) for a viral and protein control, while C57BL/6 mice were
injected with sterile saline (C57, n=60). Mice from each rAAV group
received 1.5 µL at 1x10 vg/mL (2.5µL/min) bilateral direct injections
12

into the SNpc (AP -2.8, ML ±1.4, DV -4.6) using a CED 26-gauge
needle (Carty, Lee et al.). The group of C57 mice received the same
injection parameters as the rAAV groups, instead substituting sterile
saline.
Acute MPTP administration. Six weeks following injection,
sFKN, mFKN, GFP, and C57 mice weighing between 32-41g were
serially injected with MPTP or sterile saline as an injection control for
naive C57 (nC57), as previously described (Cardona, Pioro et al.
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2006). Briefly, MPTP (Sigma Aldrich; 10mg per kg body weight) was
diluted in sterile saline and injected i.p. four times within a four hour
period. Following injections, animal cages were placed on flexible
water heating pads (37°C) for approximately 24 hours post injection in
an effort to maintain body temperature and combat mortality. After 5
days the mice were weighed, any mice that lost greater than 5% body
mass were excluded from the study.
Behavioral analysis. Five days after MPTP injections, mice
were tested for overall balance, motor coordination and motor
learning. This test was performed on an accelerating rotarod
apparatus (Ugo Basile, Italy) with a 3 cm diameter rod starting at an
initial rotation of 4 RPM accelerating to 40 RPM over 5 minutes. Mice
were tested for the time spent on the rod during each of four trials
with a 30 min inter-trial interval. Each trial was completed when the
mouse fell off the rod (distance of 12 cm) onto a spring-cushioned
lever (Rogers, Morganti et al. 2011). Following behavioral analysis,
animals were randomly divided for either perfusions or biochemical
analyses.
Immunohistochemistry. Mice were euthanized with
pentobarbital (50 mg/kg, i.p.). The mice were transcardially perfused
with phosphate-buffered saline (PBS), followed by 4%
paraformaldehyde in PBS. The brains were postfixed in 4%
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paraformaldehyde for 12 h, after which they were transferred into
30% sucrose in PBS for at least 16 h at 4°C. Exhaustive coronal
sections were made at 40µm using a Microm cryostat (Richard-Allan
Scientific, Kalamazoo Michigan) and stored in cryoprotectant at 4°C.
Labeling of dopaminergic neurons was performed using an antibody
against tyrosine hydroxlase (TH, 1:4000, Immunostar, WI). Neurons
were labeled using NeuN (Millipore, 1:500), which is a pan marker for
neuronal nuclei.

Activated microglia were visualized with antibodies

against CD68 and CD11b (Serotec 1:200). Standard staining
procedures were conducted on free-floating sections using every sixth
section for the entire SNpc beginning with a random start and
including sections before and after to ensure that the entire structure
was sampled. Following incubations (24-48hrs) with appropriate
primary and biotinylated-secondary antibodies, sections were treated
with vectastain ABC reagent (Vector labs) and visualized with DAB
reaction (Sigma). As a control measure, the specificity of all antibodies
was confirmed by omitting primary antibodies.
Stereological quantification and imaging: To determine cell
numbers, the optical fractionator method of unbiased stereological cell
counting techniques(West, Slomianka et al. 1991) was used with a
Nikon Eclipse 600 microscope and quantified using Stereo Investigator
software (MicroBrightField, Colchester, VT). The virtual grid (150 x
!

!

92!

150) and counting frame (75 x 75) were optimized to count at least
200 cells per animal with error coefficients less than 0.07. Outlines of
the anatomical structures were done using 10x/0.45 objective and cell
quantification was conducted using 60x/1.40 objective.
Cell density quantification and imaging: Cell density was
measured using a Zeiss Mirax slide scanner, as previously
described(Rogers, Morganti et al. 2011). Briefly, slides with NeuN,
CD68, and CD11b sections were scanned and converted into digital
files. Following scanning, the digital images were analyzed for positive
area using Zeiss Neuroquant IAE analysis software. An investigator
blind to the study defined the anatomical regions comprising the SNpc
for each tissue section. Positive cells were defined using the analysis
software based upon their threshold to include both the cell body and
processes, while eliminating background values. Data are represented
as the average area ratio of positive cells relative to the total
measurement area.
Biochemical analyses tissue preparation: Mice used for
biochemical studies were euthanatized by rapid decapitation. Brain
tissues encompassing the ventral mesencephalon (VM) and striatum
were separately dissected and rapidly frozen in liquid nitrogen before
storage at -80ºC. Tissues were homogenized using an electric tissue
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homogenizer in 1:10 weight to volume ratio of ice-cold RIPA buffer
(Millipore; Billerica MA) containing protease inhibitors and EDTA
(Pierce; Rockford IL). Following homogenization, sample lysates were
centrifuged at 10,000 x g at 4ºC for 15 minutes, the cleared
supernatant was collected. Protein concentration was determined using
the BCA assay (Pierce) method. Tissue lysates were used for
subsequent Western blot and ELISA analyses.
Western blot analysis. 50 µg of total protein per lane was
loaded onto a 4-15% SDS-polyacrylamide gel (BioRad; Hercules, CA)
for electrophoresis. Proteins were transferred onto a nitrocellulose
membrane for immunodetection. Membranes were subsequently
blocked for 1-hour in 5% non-fat dry milk (NFDM) in PBS-tween (PBST, 0.1% Tween20). CX3CL1 (RnD Systems, 1:750), TH (Millipore,
1:500), anti-HA (Roche, 1:500) and mouse beta-actin (Sigma;
1:3000) were incubated overnight at 4 C in 1% NFDM in PBS-T.
o

Following washes, anti-rabbit, anti-mouse, or anti-rat secondary
antibodies (Li-Cor; Lincoln NE) were incubated for 1-hour at room
temperature in 1% NFDM in PBS-T. Membranes were scanned using LiCor Odyssey near infrared imager and raw intensity for each band was
measured using Li-Cor Odyssey image analysis software.
ELISA cytokine quantification. TNFα and IL-1β concentrations
were quantified using standard ELISA technique. VM lysates were run
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in triplicate at a concentration of 100 µg per well and were incubated
over night at 4 degrees Celsius. Following incubation, manufacturer’s
suggested protocol was followed (Raybiotech; Norcross, GA).
Concentrations for each ELISA plate was subsequently measured on a
plate reader (BioTek) and adjusted to the supplied standard curve.
Values were converted from pg/mL to pg/µg of protein loaded.
Statisticsl analysis. All data were analyzed using SPSS (IBM,
v20). All data are presented as the mean± standard error of the mean

(SEM). Statistical analyses were performed using 3-way ANOVA
accounting for genotype, MPTP, and rAAV treatments. Group
differences were assessed by Tukey HSD post hoc multiple
comparisons test with p values of <0.05 considered significant.

Results
Generation of rAAV9-FKN variants and validation. Both
rAAV9-FKN variants produce a murine version of the CX3CL1 gene
driven by the hybrid chicken β-actin cytomegalovirus promoter and
were tagged with hemagglutinin (HA) peptide sequence for ease of
detection. Prior to virus production, the rAAV vector was tested in HEK
293 cells to evaluate the expression cassette. Cell lysate and
conditioned media from transfected cells were examined using
Western blot analysis to determine sFKN and mFKN expression. An
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anti-HA tag Western blot of transfected HEK 293 cells revealed that
sFKN is readily secreted into the media, while mFKN remains only in
the cell lysate fraction (Fig. 13a). We next wanted to ensure that the
synthetic FKN variants were biologically active. Briefly, conditioned
media from HEK 293 cells transfected with sFKN plasmid was used to
confer bioactivity by measuring the amount of secreted TNFα from BV2
microglia-like cells. It has been well documented that the induction of
cytokine production from microglia as a result of LPS exposure can be
blunted if the cells are pretreated with exogenous soluble CX3CL1
peptide(Zujovic, Benavides et al. 2000; Mizuno, Kawanokuchi et al. ;
Lyons, Lynch et al. 2009; Wynne, Henry et al. 2010). In accordance
with previous literature, we show that BV2 cells preconditioned with
sFKN conditioned media had an attenuated response to LPS
(100ng/mL) as measured by TNFα secretion (Fig. 13b). Furthermore,
addition of sFKN conditioned media alone did not induce TNFα
production. This attenuated response is comparable to previous
literature(Mizuno, Kawanokuchi et al. ; Lyons, Lynch et al.) given the
dilute concentration of CX3CL1 found in sFKN conditioned media. As
we were able to confer functionality and bioactivity in vitro we next
examined the expression of the rAAV9-FKN vectors in vivo. Using
CX3CL1 null mice, we injected each vector bilaterally into the SNpc.
Six weeks post injection; harvested brain tissues were analyzed for
!

!

96!

sFKN and mFKN expression by Western blot. Using an anti-mouse
CX3CL1 antibody, in vivo expressions of each of the rAAV-FKN
constructs created their specific variants of CX3CL1 consistent with
predicted molecular weights as we have previously
documented(Bachstetter, Morganti et al.)(Fig. 13c). Importantly,
mFKN produces only a single band indicating that the mutation
effectively prevents cleavage by ADAM10/17. Furthermore, direct
injection using CED method(Carty, Lee et al.) with rAAV variants
efficiently covers the entire SNpc (Fig. 13d).
MPTP induced impairment of motor coordination is
ameliorated by sFKN but not mFKN. We next assessed the effects
of each rAAV-FKN treatment on MPTP-induced motor deficits using an
accelerating rotarod. Naive CX3CL1 null mice displayed no motor
coordination impairment relative to nC57 (data not shown). Five days
after the last MPTP injection, all groups displayed a trend for
performance impairment (p<.001) as measured by average latency to
fall through first three trials compared to nC57 (Fig. 14). Treatment
with sFKN significantly improved MPTP-induced behavioral deficits
compared to mFKN (p=.002) and GFP (p<.001) viral control. Following
rotarod performance assessment, mice were killed and striatal tissues
were dissected for biochemical analysis. In agreement with each
group’s rotarod performance, WB analysis revealed significant loss of
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striatal TH as a result of MPTP administration (p<.001), ranging from
40-75% (Fig. 15a). Furthermore, sFKN treatment was able to
attenuate exhaustive striatal TH loss by 35 and 30 percent compared
to mFKN (p<.001) or GFP groups (p<.001), respectively.

MPTP induced neurodegeneration of SNpc is rescued by
sFKN. It has been previously documented that disruption of CX3CL1
signaling via genetic ablation of CX3CR1 exacerbates MPTP
neurotoxicity in SNpc of mice(Cardona, Pioro et al.). Seven days after
the last MPTP injection mice were transcardially perfused with a
buffered paraformaldehyde solution and brain tissues removed. We
evaluated the level of MPTP induced neurodegeneration in the SNpc
through stereological quantification of TH and density of NeuN
staining. Both TH immunoreactive (Fig. 16) and NeuN (Fig. 17) labeled
neurons mimicked our striatal TH Western blot data. Additionally, agematched naive CX3CL1 mice showed no significant reduction in the
-/-

number of TH positive or density of NeuN stained neurons relative to
nC57, indicating that genetic disruption of CX3CL1 signaling alone
does not produce a phenotype (data not shown). Compared to nC57,
MPTP produced a marked reduction in the estimated number of TH
positive cells across all groups (p=.05). sFKN treatment attenuated
MPTP induced dopaminergic cell loss compared to mFKN (p=.003) and
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GFP (p<.001) treated animals. Likewise, sFKN but not mFKN
maintained the density of NeuN labeled neurons in the SNpc
Administration of MPTP does not alter CX3CL1-CX3CR1
signaling. With the present study we are the first to examine MPTP
effects on CX3CL1 signaling. Recent literature has suggested that
acute inflammatory insults can down-regulate both transcript and
protein levels of CX3CR1 on microglia (Kremlev and Palmer ; Wynne,
Henry et al.). We analyzed VM tissue lysate using Western blot
analysis for CX3CR1 (Fig. 18a). Here we are the first to report that
acute exposure to MPTP does not affect (p=.26) the protein levels of
CX3CR1 in vivo. Additionally, neither the presence of the individual
rAAV-FKN variants nor the complete absence of CX3CL1 in the GFP
group alters CX3CR1 protein levels in the VM. These data would then
suggest that expression of CX3CR1 is not only constitutive (Harrison,
Jiang et al.) but independent of CX3CL1 type and concentration in the
surrounding milieu. Additionally, we quantified the production of
CX3CL1 from each rAAV-FKN in the VM. Each rAAV-FKN was able to
virtually restore CX3CL1 levels to that of nC57 and importantly sFKN
and mFKN produced similar concentration of CX3CL1 (Fig. 18b).
Furthermore, here we show for the first time that MPTP does not affect
the production of CX3CL1 (nC57 vs. C57; p>.05).
Induction of CD68 and CD11b reactive microglia is
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attenuated by sFKN. Microglial activation has been implicated in the
propagation of SNpc neurotoxicity in multiple animal models of PD.
Recent studies further report that an intact CX3CL1 to CX3CR1
signaling axis to dampen the neurotoxic effects of both 6-OHDA and
MPTP(Cardona, Pioro et al. ; Pabon, Bachstetter et al.). Post-mortem
analysis of idiopathic PD patients has revealed strong
immunoreactivity for CD68, a marker of phagocytic microglia (Croisier,
Moran et al. ; Vroon, Drukarch et al.). Furthermore, administration of
MPTP has been reliably shown to induce this phagocytic microglia
phenotype in the SNpc of mice (Vroon, Drukarch et al. ; Chung, Kim et
al. ; Chung, Kim et al.). Quantification of CD68 positive cells revealed
a significant induction of microglia reactivity (Fig. 19a) as a result of
MPTP injections compared to saline (p=.02). CD68 immunoreactivity
was most profound in both the mFKN (p=.001) and GFP (p<.001)
treated groups compared to sFKN. Furthermore, sFKN treated mice
resembled that of nC57 (p>.05) in that there were very few CD68
positive microglia (Figs. 19b, d). Here our data also show that mice
treated with mFKN (Fig. 19e) have a CD68 phenotype similar to mice
expressing GFP (Fig. 19f, p>.05).
We next analyzed broader marker for microglia activation using
an antibody for CD11b. Immunolabeled CD11b microglia have
previously been shown to increase reactivity following administration
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of the dopaminergic neurotoxin MPTP in the SNpc(Wu, Teismann et al.
; Chung, Kim et al.). Mice exposed to MPTP had a significant increase
in CD11b reactive microglia (Fig. 20a) compared to those that received
saline injections (p<.001). Mice that received sFKN injections again
presented a similar CD11b expression phenotype as nC57 (p>.05).
Further, a strong induction of CD11b density was observe in the SNpc
of both mFKN (Fig. 20e, p<.001) and GFP (Fig. 20f, p=.002) treated
mice compared to sFKN. Additionally, CD11b immunoreactivity was
similar between mFKN and GFP treated mice (p>.05).
Expression of MPTP induced pro-inflammatory cytokines is
diminished by sFKN. Post-mortem analysis of PD tissue has shown
that microglia that are immunoreactive for multiple pro-inflammatory
cytokines including TNFα and IL-1β(McGeer and McGeer 2004).
Further, mice that are genetically altered to inhibit cytokine production
or are deficient in receptors for these cytokines provide
neuroprotection in the SNpc following MPTP exposure (Klevenyi,
Andreassen et al. ; Sriram, Matheson et al.). Accordingly, as CX3CL1
signaling has been shown to attenuate the production of these
cytokines in vitro and in vivo following various inflammatory stimuli,
we sought to examine the anti-inflammatory properties of each rAAVFKN variant in response to MPTP exposure. Tissue lysate of the VM
(brain region containing SNpc) were analyzed using standard ELISA
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techniques for the pro-inflammatory cytokines TNFα and IL-1β. MPTP
treatment significantly upregulated the production of TNFα (Fig. 21a,
p<.0001) and IL-1β (Fig. 21b, p<.0001) compared to all treatment
groups. These findings are consistent with our data showing an
increase in activated microglia (CD11b+ and CD68+) following
exposure to MPTP. Interestingly, sFKN attenuated the production of
both TNFα (p<.001) and IL-1β (p<.001) compared to mFKN and GFP
treated mice. Comparably, the production of both cytokines mimicked
levels found in MPTP injected C57.
Discussion
Disruption of CX3CL1-CX3CR1 signaling in the brain exacerbates
MPTP induced DA neurodegeneration(Cardona, Pioro et al.).
Functionally, this signaling pair has been shown across a variety of
studies to dampen microglial activation and subsequent toxicity. Until
now, it has been difficult to isolate the individual effects of the two
forms of CX3CL1. We have developed a novel method to examine the
individual properties of each CX3CL1 form through the use of rAAV
gene therapy in CX3CL1 null mice. Our study demonstrates that only
sFKN is sufficient in attenuating the neurotoxic effects of MPTP on the
nigrastriatal network. We show that treatment with sFKN reduces
impairment of motor coordination, prevents exacerbation of DA neuron
loss, ameliorates microglia activation and proinflammatory cytokine
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release, all of which are commonly associated with the MPTP mouse
model of PD.
These important discoveries provide novel insight into the role
for CX3CL1 signaling in an acute inflammatory state. We have
previously reported that an exogenous truncated (i.e. soluble) peptide
of CX3CL1 was able to reduce 6-OHDA associated neurotoxicity in a rat
model of PD(Pabon, Bachstetter et al.). However, this model still left
unaccounted the actions of the full-length membrane-bound CX3CL1
subtype, as native CX3CL1 (both soluble and membrane bound) was
still present in these animals. Additionally, Lyons et al.(2009)(Lyons,
Lynch et al.) concluded that membrane-bound CX3CL1 possesses the
same anti-inflammatory abilities as its soluble counterpart. However,
Lyons et al. (2009)(Lyons, Lynch et al.) neglected to inhibit the
constitutive cleavage mechanism of ADAM10/17 in their experimental
paradigm. Here we have addressed this concern by mutating the
known cleavage site of CX3CL1, thus preventing the soluble variant
from being produced. Furthermore, by using CX3CL1 null mice, we
were able to isolate the effects of each rAAV-FKN variant in response
to MPTP.
In the present study we have developed two novel rAAV vectors
that each produce a single form of CX3CL1, either a solely soluble or
permanently membrane-bound form. We show that in vitro the peptide
!

!

103!

created by the sequence encoding sFKN attenuates the LPS-induced
secretion of TNFα from BV2 cells. Furthermore, Western blot analysis
of both in vitro and in vivo expression of each rAAV-FKN variant results
in a solely soluble (sFKN) or mutated form that remains permanently
attached to the neuronal membrane (mFKN). Additionally, the method
of CED vector delivery (Carty, Lee et al.) efficiently saturated the SNpc
target area with the bilateral vector bolus as confirmed by GFP
expression in CX3CL1 null mice.
Following the MPTP and saline injections, all mice were subjected
to behavioral analysis to examine motor coordination. As one of the
primary pathological hallmarks of PD in humans is motor coordination
dysfunction (Bezard and Przedborski), it was important to characterize
the effect that each type of our rAAV-FKN variants had on preventing
motor coordination impairment. Five days after injection, mice
exposed to MPTP displayed significant deficits in latency on rotarod
apparatus compared to saline injected mice. This MPTP induced latency
deficit was significantly ameliorated by treatment with sFKN,
resembling that of nC57. Additionally, the full-length CX3CL1 variant
produced by mFKN provided no amelioration of MPTP induced
reduction of latency, as mice more closely resembled the phenotype of
GFP injected animals.
A pathological hallmark of PD is neurodegeneration in the SNpc
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leading to a selective loss of DA neurons. The subsequent depletion of
DA projections to the striatum leads to impairments in motor
coordination. As we had observed a significant impairment in latency
on rotarod as a result of MPTP exposure, we next examined the
neuroprotective effects of each of our rAAV-FKN variants. Since TH is
the rate limiting enzyme controlling the production of DA, we used this
as a marker to selectively visualize DA neurons in the SNpc. Previous
literature has shown an exaggerated response to MPTP in CX3CL1
deficient mice(Cardona, Pioro et al. 2006). Mirroring the impaired
motor coordination, we found a significant reduction of available TH in
the striatum of MPTP treated mice. Mice expressing sFKN had
significantly more available TH in the striatum compared to both mFKN
and GFP expressing mice. Furthermore, stereological analysis revealed
a significant depletion of the number of TH positive cells in the SNpc in
response to MPTP. This depletion was again ameliorated by treatment
with sFKN. Mimicking what was observed with latency on rotarod,
mFKN treated mice had significantly less TH positive neurons
compared to sFKN and resembled those treated with GFP, the rAAV
control vector. As expression of TH has been shown to be somewhat
plastic in response to MPTP and therefore a decline in TH is not
necessarily an indicative marker of degenerative DA neurons (JacksonLewis, Jakowec et al. 1995). In order to accurately assess whether
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neuronal loss was occurring, we next measured the density of NeuN in
the SNpc. Our data show that the neuronal loss associated with MPTP
administration is recovered by administration of sFKN, while
exacerbated by either mFKN or mice that lack any CX3CL1 (GFP).
CX3CL1 to CX3CR1 communication is one way that neurons are
thought to directly interact with microglia. Several studies have
indicated that an acute inflammatory insult such as LPS exposure is
sufficient to disrupt this dialog via down regulation of CX3CR1
transcript and protein levels. Here we show for the first time that
exposure to acute administration of MPTP does not affect the signaling
capabilities of this pair as both CX3CR1 and CX3CL1 protein levels
remain unchanged in response to MPTP exposure. Importantly, each of
our rAAV-FKN variants restores CX3CL1 back to levels seen in wildtype mice.
As the aberrant activation of microglia has been shown to
exacerbate the pathophysiology associated with PD, we examined how
each rAAV-FKN variant was able to attenuate this response after
administration of MPTP. Our results indicate that sFKN was able to
abrogate the induction of CD68 phagocytic microglia, while mFKN
dramatically induced this activation state akin to the phenotype
present in animals injected with GFP control vector. Likewise, CD11b
reactive microglia were markedly reduced in mice that expressed sFKN
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compared to both mFKN and GFP groups. Moreover, in vitro, the
truncated (soluble) CX3CL1 peptide has been shown to reduce the
production of multiple pro-inflammatory molecules (Zujovic, Benavides
et al. 2000; Zujovic, Schussler et al. ; Biber, Neumann et al. ;
Mizutani, Sakurai et al. 2007). Our current data show that sFKN
attenuates the production of both IL-1β and TNFα in the VM of MPTP
injected mice. Furthermore, mice expressing only the membranebound form had significantly higher levels of both pro-inflammatory
cytokines, again presenting an inflammatory phenotype similar to GFP
expressing mice.
There has been a recent surge in the literature regarding the role
for CX3CL1 signaling in both physiological and pathological conditions.
We have recently shown that genetic disruption of CX3CL1 signaling is
sufficient to impair cognitive function (Rogers, Morganti et al.), while
others have demonstrated both neuroprotective (Lee, Varvel et al.)
(Fuhrmann, Bittner et al.) and neurotoxic (Bhaskar, Konerth et al.)
effects of CX3CL1 signaling. Here we report a novel interaction
wherein CX3CL1 mediated anti-inflammatory control of microglia is
solely through the soluble form, in a MPTP mouse model of PD. In this
model, through the sole interactions of sFKN and CX3CR1 we
demonstrate amelioration of impaired motor coordination is attributed
through a reduction in microglia activation and subsequent pro!
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inflammatory response. These effects are completely absent in mice
expressing only a membrane-bound form of CX3CL1.
Given that only the soluble form of CX3CL1 provides an antiinflammatory and therefore neuroprotective function we suggest a new
signaling paradigm wherein ligation with the soluble form allows for
CX3CR1 internalization. Recent literature has indicated that multiple
chemokine receptors actively retreat through internalization to the
cytoplasm following ligation to affect downstream signaling pathways
(Neel, Schutyser et al. 2005; Borroni, Mantovani et al. 2010).
Furthermore, chemokine receptor internalization may therefore play an
important role in chemokine signaling capabilities. Given our recent
data that show the anti-inflammatory capacity of CX3CL1 resides
solely on the soluble form it is plausible that CX3CR1 internalization is
functional aspect of this signaling system. Although ligation of mFKN
with CX3CR1 is possible through the chemokine domain, its permanent
attachment to the membrane may prevent subsequent internalization
to the cytoplasm of microglia, thereby alter any downstream effectors.
Therefore, only a soluble domain of CX3CL1 can be readily ligated and
internalized with CX3CR1. Recent literature corroborate this idea in
that CX3CR1 actively removes soluble CX3CL1 from the surrounding
milieu, as CX3CR1 null mice have substantially more circulating
CX3CL1(Cardona, Sasse et al. 2008). Moreover, this justifies the need
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for the constitutive and endogenous proteolytic cleavage by
ADAM10/17 to yield soluble CX3CL1 in an effort to maintain a constant
neuroprotective dialog between neurons and microglia.
We’ve created two very effective tools to examine the signaling
characteristics of the two native forms of CX3CL1. Although we used
an acute inflammatory model to examine these effects, it’s worth
noting that the relationships we detailed in this study may not apply to
all inflammatory related neurodegenerative conditions. Further
examination of both of the CX3CL1 subtypes in various animal models
of neuroinflammation and degenerative disease models are necessary
to continue our understanding of this unique chemokine signaling pair.
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Figure 13. Generation of rAAV-FKN variants. (A) Western blot analysis of
sFKN (s), mFKN (m), and GFP expressed in 293 cells using an antihemagglutinin antibody. Only sFKN was detected in the media. (B)
ELISA quantification of BV2 secreted TNFα. Pre-treatment with sFKN
conditioned media attenuates (p<.05) the secretion of TNFα from BV2
cells when exposed to 100ng of LPS for 4hrs. sFKN alone does not
induce the secretion of TNFα. (C) Western blot analysis of in vivo
expression of sFKN (s) and mFKN (m) using an anti-CX3CL1 antibody.
Both sFKN (s) and mFKN (m) produce a single band consistent in
molecular weight with previous literature. Importantly, mFKN (m) yields
only a single band indicating that endogenous ADAM10/17 proteolytic
cleavage is prevented. (D) In vivo transduction of rAAV-GFP in the SNpc
neurons (inset). CED vector delivery resulted in complete coverage of
the SNpc. Scale bar is 200µm. Data are presented as mean±SEM.
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Figure 14. MPTP induced impairment of motor coordination is
rescued by sFKN. Five days after the last injection of MPTP, mice
were subjected to behavioral analysis to analyze balance and
coordination on an accelerating rotarod. Motor coordination was
assessed using the first three of four trials during training. As a
whole, MPTP induced significant deficits in motor coordination
through the first three trials compared to nC57 (Repeated
measures ANOVA; p<.001). Treatment with sFKN attenuated MPTP
induced coordination deficits compared to mFKN (p=.002) and GFP
(p<.001). Data are presented as mean time in seconds as a
percentage of nC57 ± SEM.
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Figure 15. Western blot analysis of TH in Striatum. Both hemispheres of the striatum
were rapidly dissected seven days after the last MPTP injection for biochemical
analysis. (A) Western blot analysis revealed that MPTP significantly reduced, by
approximately 40% the availability of TH in the striatum compared to saline control
nC57 (p=.002). Mice that received sFKN had an attenuated loss of TH in the striatum
compared to mFKN (p<.001) and GFP (p<.001). Furthermore, mFKN and GFP groups
displayed approximately a 76% and 70% reduction in TH, respectively. (B-F)
Representative immunostaining in the striatum shows progressive loss of TH for (B)
nC57, (C) C57, (D) sFKN, (E) mFKN, and (F) GFP groups. Data are presented as the
mean band density ratio (n=5 per group) of TH to Actin as a percentage of nC57 ±
SEM. au= arbitrary units. Scale bar equals 200µm.
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Figure 16. Stereological analysis of TH-positive neurons in SNpc. TH
immunoreactivity was analyzed in the SNpc of mice seven days after
the last MPTP injection. (A)Exposure to MPTP resulted in a marked
reduction in the number of TH-positive cells in the SNpc (p=.05)
compared to saline treated nC57 mice. sFKN provided the greatest
TH-neuroprotection relative to mFKN (p=.003) and GFP (p<.001). (BF) Representative immunostaining for TH in SNpc for (B) nC57, (C)
C57, (D) sFKN, (E) mFKN, and (F) GFP. Data are presented as mean
estimate of TH positive cells (n=6 per group) as a percentage of nC57
± SEM. Scale bar equals 200µm.
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Figure 17. Densitometric analysis of NeuN positive neurons in the
SNpc. NeuN immunoreactivity was quantified in the SNpc of mice
from tissue taken seven days after last MPTP injection. (A)
Densitometric analysis of NeuN immunostaining in the SNpc
revealed a significant decline in immunoreactivity due to MPTP
exposure compared to saline (p<.01). Additionally, sFKN mice had
significantly more NeuN positive cells in the SNpc compared to
mFKN (p<.05). There was no difference between mFKN and GFP
groups as well as an analogous trend for mFKN and GFP compared
to sFKN. (B-F) Representative staining for NeuN in SNpc for (B)
nC57, (C) C57, (D) sFKN, (E) mFKN, and (F) GFP. Data are
presented as mean ± SEM. Scale bar equals 200µm.
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Figure 18. MPTP does not adversely affect CX3CL1-CX3CR1 signaling in VM.
Tissue lysates from the VM of each group were analyzed for protein levels of
CX3CR1 by Western blot and CX3CL1 by ELISA. (A) Western blot analysis of
VM tissue lysate using an anti-CX3CR1 antibody revealed no significant
changes as a result of either MPTP or saline injections. Furthermore, neither
the presence nor absence of CX3CL1 affected protein levels of CX3CR1. (B)
Standard ELISA technique was used to quantify total CX3CL1 levels.
Exposure to MPTP did not affect the production of CX3CL1 (nC57 vs. C57).
Furthermore, each rAAV-FKN variant expressed approximately the same
amount of CX3CL1 and importantly restored CX3CL1 to that of levels wild
type (nC57) mice. Data are presented for Western blot as the mean band
density ratio (n=5 per group) of CX3CR1 to Actin ± SEM. au= arbitrary units.
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Figure 19. MPTP significantly induces expression of CD68 reactive
microglia. (A) Densitometric analysis of CD68 immunoreactive
microglia in the SNpc. CD68 immunoreactivity was noticeably absent
in both nC57 and sFKN groups. Additionally, sFKN treatment
prevented the abberrant accumulation of CD68 microglia compared to
both mFKN (p=.001) and GFP (p<.0001). (B-F) Representative CD68
reactive microglia immunostaining in the SNpc shows aberrant
accumulation of activated microglia for (B) nC57, (C) C57, (D) sFKN,
(E) mFKN, and (F) GFP groups. Data are presented as the mean band
density ratio (n=5 per group) of TH to Actin as a percentage of nC57
± SEM. Scale bar equals 200µm.
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Figure 20. MPTP significantly induces expression of CD11b
reactive microglia. (A) Densitometric analysis of CD11b
immunoreactive microglia in the SNpc. sFKN treatment
prevented the abberrant accumulation of CD11b microglia
compared to both mFKN (p=.0001) and GFP (p<.002). (B-F)
Representative CD11b reactive microglia immunostaining in the
SNpc shows aberrant accumulation of activated microglia for (B)
nC57, (C) C57, (D) sFKN, (E) mFKN, and (F) GFP groups. Data
are presented as the mean band density ratio (n=5 per group)
of TH to Actin as a percentage of nC57 ± SEM. Scale bar equals
200µm.
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Figure 21. MPTP induction of pro-inflammatory cytokines is
ameliorated by sFKN. Tissue lysate from VM of each group (n=5 per
group) was analyzed to quantify the production of the proinflammatory cytokines TNFα and IL-1β. (A) MPTP induced
production of TNFα is ameliorated by sFKN compared to mFKN (p<.
0001) and GFP (p=.0009). (B) Quantification of IL-1β levels
revealed the same trend, as sFKN significantly attenuated
production compared to mFKN (p=.001) and GFP (p=.0009). Data
are presented as the mean ± SEM.
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Conclusions: CX3CL1-CX3CR1 signaling axis regulates cognitive
function and combats neurodegeneration through governing of
microglia activation.
Introduction
Neuroinflammation is widely recognized as a contributing factor to
the progression of many neurodegenerative diseases such as AD and
PD. It is both axiomatic and problematic the inherent role that
neuroinflammation plays in aging and cognitive function, as well as
progression of neurodegenerative pathology. To this point, it has been
suggested that the process of aging in the brain, through a lifelong
accumulation of various insults, transforms the innate immunological
response to a chronically inflamed state, thus predisposing itself to
neurodegenerative disease (Blasko, Stampfer-Kountchev et al. 2004).
It is not surprising then the correlation between the use of antiinflammatory drugs and the reduced risk of developing
neurodegenerative pathology (Chen, Zhang et al. 2003). Likewise, the
CNS has several endogenous anti-inflammatory signaling mechanisms
to combat development of inflammation. Here, in the preceding
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chapters we analyzed how CX3CL1 anti-inflammatory effects impact
cognitive function and progression of neurodegeneration.
Microglia: the brain’s double agent.
The brain’s resident immune cells, acting in much the same way
as peripheral macrophages, are microglia. While histology has
revealed that microglia densities vary regionally within the brain, it
must be noted that both the hippocampus and substantia nigra contain
the highest concentrations (Lawson, Perry et al. 1990; Kim, Mohney et
al. 2000). Under non-pathological conditions in the mature brain,
microglia are typically found in a resting state with small soma and
highly ramified projections to monitor their surrounding environment
(Nimmerjahn, Kirchhoff et al. 2005). Continuing controversy exists as
to the exact nature of microglia, whether they are inherently
neuroprotective or neurotoxic when activated. When presented with
certain immunological cues or insults such as brain injury, microglia
become promptly activated (Fetler and Amigorena 2005). The term
‘activation’ when referring to microglia often carries a harmful
connotation, which is not always the case. Microglia activation can
have a beneficial role, they remove neural cells programmed for death
and facilitate formation of synapses in the developing brain (Upender
and Naegele 1999; Paolicelli, Bolasco et al. 2011), and release antiinflammatory and trophic factors (Morgan, Taylor et al. 2004).
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However, as the previous chapters have highlighted, activation of
microglia often result in a cytotoxic response, with damaging effects
on nearby neurons. If microglia simply existed as cytotoxic
contributors, the clear therapeutic treatment would be ablation of
function entirely. Notwithstanding, it has been shown that indeed the
brain does need controlled cytotoxic responses in order to curtail long
lasting damage (Gemma, Catlow et al. 2007).

Cytokines: a necessary evil.
It is difficult to pinpoint the exact cause or specific mechanisms
related to the cognitive impairments associated with inflammation as
there are likely many. Further complicating the matter is the
involvement of cytokines in the maintenance of synaptic function.
Although the over production of cytokines in response to various
stimuli can negatively affect many neural functions, it then would
seem almost counterintuitive that these very products are actual
necessities for proper cognitive function. One of the more widely
studied cytokines that has this dual nature of beneficial and toxic is IL1B (Goshen, Kreisel et al. 2007). As such, it has been shown that IL1B signaling follows an inverted curve; lower concentrations are
beneficial (Brennan, Beck et al. 2003) if not necessary, while higher
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concentrations impair synaptic plasticity (Rachal Pugh, Fleshner et al.
2001). Corroborating this idea are data showing that knock-out of IL-1
receptor in mice resulted in impaired memory, which coincided with
reductions is synaptic plasticity (Avital, Goshen et al. 2003), whereas
over-expression of IL-1B resulted in impaired LTP-associated learning
(Deak 2007).
Another cytokine with pleiotropic actions is TNFa. This proinflammatory cytokine has been shown to provide physiological
(Cheng, Christakos et al. 1994), neuroprotective (Gemma, Catlow et
al. 2007), and neurodegenerative (Perry, Collins et al. 2001) effects.
Therefore it may be difficult to establish a unique role for this cytokine
in the CNS, which may be in part to due its receptors. An idiosyncrasy
of TNF are its two receptor subtypes (r1 and r2); both of which may
have different signaling purposes. TNF-r1 is for the most part thought
of as the inflammatory component of TNF mediated inflammation, in
that it has been shown to activate caspases (MacEwan 2002). While
TNF-r2 appears to have the opposite effects due to a lack the
apoptosis signaling domain present in TNF-r1 (MacEwan 2002). The
exact role of TNF signaling as it relates to synaptic plasticity is not well
defined, however recent literature seem to implicate a role for
modulation of glutamatergic signaling. Interestingly, TNF may upregulate the expression of AMPA receptors at the synapse, while
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simultaneously down-regulating GABA receptors through endocytosis;
resulting in a net increase of synaptic signaling (Stellwagen, Beattie et
al. 2005). Coincidentally, the tight regulation of AMPA receptors at the
synapse is important for both LTP and LTD (Malenka and Bear 2004).
Thus it may be plausible that low levels of TNF are responsible for
regulating synaptic plasticity.
Related to synaptic plasticity and its impacts on cognitive
function, microglia and their respective pro-inflammatory mediators
are, in essence, a necessary evil. Both the over production and
absence of cytokines have been shown to affect hippocampal
dependent forms of cognitive function and synaptic plasticity. As such,
a cytokine model of cognitive function (McAfoose and Baune 2009),
has been proposed due to the inherent nature for cytokines to regulate
synaptic plasticity and ultimately cognitive function.
We have demonstrated that disruption of CX3CL1 signaling by
genetically removing CX3CR1 leads to impairments in synaptic
plasticity and cognitive function. Furthermore, these impairments are
related to a chronic overproduction of both IL1B and TNFa relative to
wild-type mice. Additionally, ventricular infusion of IL-1ra recovered
cognitive deficits associated with CX3CR1 null mice, suggesting a
prominent link between CX3CR1 deficiency, IL1B production, and
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synaptic plasticity. While we did observe increased TNFa in the
cerebellum of CX3CR1 null mice, we would also assume the same
increase exists in the hippocampus. To that end, blockade of TNF
production has been shown to recover cognitive deficits in AD patients
(Tobinick and Gross 2008; Tobinick 2009), therefore administration of
TNF blocking compounds could yield similar results as IL-1ra in our
current study.
Although genetic ablation of CX3CR1 resulted in a chronic
inflammatory phenotype, we used another approach to examine
chronic neuroinflammation. By using low-dose infusion of LPS into the
third ventricle we were able to trigger a strong microglia inflammatory
response. As a result, rats infused with LPS showed significant
impairments in novel place recognition, a preferentially hippocampal
dependent task (Morris, Garrud et al. 1982; Mumby, Gaskin et al.
2002; Barker and Warburton 2011) but not novel object recognition, a
task that relies on the perirhinal cortex (Steckler, Drinkenburg et al.
1998; Aggleton and Brown 1999; Mumby, Gaskin et al. 2002; Barker
and Warburton 2011). This behavioral phenotype is highly consistent
with the fact that neuroinflammation is primarily distributed within the
hippocampus in our model (Rosi, Ramirez-Amaya et al. 2005; Rosi,
Vazdarjanova et al. 2006) and further demonstrates the high
vulnerability of the hippocampal formation toward neuroinflammation.
!

!

124!

Interestingly, as a result of chronic LPS exposure, CX3CR1 was
dramatically reduced in the hippocampus. Analogous to our study with
CX3CR1 null mice, we observed a dramatic induction of TNFa as well
as signaling components involved in the propagation of
neuroinflammation.
Although we used two distinct models to study chronic
neuroinflammation, parallels can be drawn from both. In general, the
resultant exposure to chronic supraphysiological levels of cytokines
resulted in impairment of cognitive function. As chronic
neuroinflammation has previously been shown to alter glutamatergic
signaling {Fine, 1996, r04380; Espey, 1998, r04381}, it is plausible to
hypothesize that the increase in neuroinflammation we observed in
both studies altered glutamate signaling and/or excitotoxicity. To this
point, administration of a non-specific NMDAr antagonist reversed
glutamatergic related cognitive impairments induced by chronic LPSinfusion (Rosi, Vazdarjanova et al. 2006). Moreover, CX3CL1 has been
shown to protect hippocampal neurons from glutamate mediated
exicitoxicity in the rat brain (Limatola, Lauro et al. 2005). While both
of our studies further corroborate a role for cytokines and their
regulation of cognitive function, it is still difficult to establish an exact
mechanism. Further characterization of the pleiotropic functions of
various cytokines is needed to fully realize their roles in the modeling
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of synapses and cognitive function.
CX3CL1: a potent regulator of microglia.
While the ablation of microglial activity would prove detrimental
on many levels, mechanisms (endogenous or therapeutic) are needed
to limit the production of cytokines and other inflammatory factors.
Constitutive expression of several ligand-receptor pairs such as
CD200-CD200r, SIRPalpha-CD47, CD22-CD47, and CX3CL1-CX3CR1
allow neuron-microglia communication (Hoek, Ruuls et al. 2000;
Cardona, Pioro et al. 2006; Bessis, Béchade et al. 2007). All of these
signaling pairs have been shown to have roles to regulate microglia
reactivity. Importantly, these signaling pairs do not control microglia in
a polar sense, in that presence does not entail microglial activity
inhibition. Which contrasts sharply with known inhibitory molecules
such as IL-10, TGFb, glucocorticoids, and minocycline. In that sense,
constitutive neuron-microglia signaling should be thought of as a
regulator of activation, wherein disruptions (e.g. neuronal damage) in
these signaling pairs could be a key signal to shift into different
activation phenotypes as previously described.
CX3CL1 signaling has been implicated in the regulation of
neurotoxic microglia in a variety of pathological conditions, as
previously reviewed. However, we were able to isolate the effects of
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the two endogenous subtypes of CX3CL1 in an MPTP mouse model of
PD. Subsequently, we have begun to establish that only the soluble
subtype of CX3CL1 possesses the ability to regulate microglia toxicity
in light of exposure to MPTP. This model presents an interesting
paradigm to study CX3CL1 effects on microglia activation. As
previously mentioned, the area affected (SNpc) is highly susceptible to
damage due to an inability to cope with oxidative stress and high
concentrations of microglia. In light of these observations, MPTP
exposure results in a toxic insult that is multifaceted and self
propagating. To this point, MPTP or its metabolite MPP+ has no known
direct link (or receptor) with microglia, activation of microglia is a
secondary inflammatory response to degenerating neurons, which in
turn creates a neurotoxic microenvironment surrounding the
degenerative DA neurons. The perpetuating insult will in turn damage
by-standard neurons (DA and non) that are healthy, creating a vicious
feed back loop. When dysregulation of microglia occurs through
disruption of CX3CL1 signaling, either the absence of CX3CL1 or the
presence of only a membrane-bound form, MPTP driven neurotoxicity
is exacerbated. While the idea that removal of CX3CL1 signaing
exacerbates neurotoxicity was previously well established(Cardona,
Pioro et al. 2006), our findings detailing the inability for the
membrane-bound form to regulate microglia toxicity are quite unique.
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These findings are confusing in the sense that the membrane-bound
form still possesses an identical signaling domain as its soluble
contemporary. This could be accounted by assuming that neurons do
not physically contact with microglia, however this has been shown not
to be the case (Paolicelli, Bolasco et al. 2011). Contrary to our chronic
models, MPTP does not affect CX3CR1 availability, so there is signaling
capability on microglia. Herein lies a difficult interpretation of our
results. There are distinct possibilities regarding the apparent passivity
of the membrane-bound subtype of CX3CL1.
First, the two subtypes of CX3CL1 are anti-inflammatory (soluble)
or neurotoxic (membrane-bound). In this sense, the accumulation of
activated microglia, induction of inflammation, and subsequent
neuronal damage are due to signaling from the membrane-bound
subtype. This could be plausible as peripheral immune cells have been
shown to up regulate inflammatory factors in response to membranebound CX3CL1 (Yoneda, Imai et al. 2003). However, in our model this
does not seem as likely. Proteolytic cleavage of CX3CL1 from
membrane is constitutively mediated by ADAM10/17. Notably,
ADAM17 is also responsible for cleavage of pro-TNFa to its active form.
As there is a subsequent induction of TNFa in MPTP treated mice, it
must be assumed that this cleavage mechanism is still functionally
intact. For the membrane-bound form to have a functional
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significance, or inflammatory signaling role there would have to be a
coincidental alteration of ADAM17 activity and subsequent downregulation of TNFa production. Thus, this would imply a TNFindependent, possibly inflammasome related pathway of membranebound CX3CL1 inflammatory signaling. Here our data would suggest
otherwise, as there was strong inductions of both pro-inflammatory
pathways. Additionally, the proteolytic cleavage of CX3CL1 actually
appears to be induced by toxic insult preceding neuronal damage
(Chapman, Moores et al. 2000). The concomitant link between TNFa
production and the solubilization of CX3CL1 would then suggest a
modulatory role. A case for retaining the membrane-bound form may
difficult to resolve as it seems to remain passive in response to MPTP
exposure. Function of various types of chemokine receptors rely on
downstream signaling induced by receptor internalization. The
passivity of membrane-bound CX3CL1 could be resolved by the
hypothesis that remaining attached the membrane prevents receptor
internalization after binding, thus preventing similar anti-inflammatory
actions as its soluble contemporary. Multiple chemokine receptors
internalize following ligation to affect downstream signaling pathways
(Neel, Schutyser et al. 2005; Savarin-Vuaillat and Ransohoff 2007;
Borroni, Mantovani et al. 2010). Functionally, this hypothesis could be
tested by using sodium azide(Chen, Luo et al. 2002) to inhibit receptor
!

!

129!

internalization comparing mFKN versus sFKN using similar outputs as
our MPTP study.
Our MPTP model evaluating the various subtypes of CX3CL1
yielded some very intriguing results that may ultimately create more
questions than it answers. The predominant question is the ambiguity
of membrane-bound CX3CL1 in neurotoxic environments. At least in
our model, we show that this subtype is passive in that it doesn’t
provide the same neuroprotective effects as its soluble contemporary.
It may be that attachment to the membrane provides a repository
type function, essentially banking unneeded CX3CL1 in case various
insults or inflammatory events present themselves. Due to the toxic
pathway of MPTP, in our model the soluble CX3CL1 subtype acts as a
triage mechanism, preventing exacerbation of neurotoxicity.
Conclusion
An axiom of aging is a concomitant increase in
neuroinflammation, which may predispose the brain to development of
cognitive impairment (dementia) as well as neurodegenerative
diseases such as AD and PD. The exact mechanisms underlying
increased inflammation in the brain remain ambiguous. However, what
is apparent is the need to regulate neuroinflammation, so that host
defense responses to insult, injury and infection are viable yet
!

!

130!

restrained. Inflammatory responses must be appropriately gated to
suit such events in order to prevent aberrant accumulation proinflammatory molecules/mediators. Implications of unregulated
chronic and acute neuroinflammation were demonstrated in the
previous three chapters’ findings. Furthermore, a novel tool for
examining the various nuances of CX3CL1 signaling was created and
future implications in other neurodegenerative models such as AD
remain unknown. As such, future studies may be able to define a role
for membrane-bound CX3CL1, where our PD model could not.
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